Fowler Syndrome

Mendelian MONDO:0009168 Pathograph 24 Show in embeddings browser Inherited Cerebrovascular Disorder Fetal Akinesia Deformation Sequence Disorder

An autosomal recessive disorder of central nervous system angiogenesis caused by biallelic variants in FLVCR2, delineated by Fowler in 1972 as a stereotyped lethal fetal phenotype and molecularly solved in 2010. The defining lesion is not a malformation of brain tissue but of the vessels that supply it: abnormally thickened, aberrant perforating vessels form glomeruloids of poorly organised endothelium throughout the CNS and retina. Everything else follows from that vasculopathy. The brain is destroyed rather than mis-built - hydranencephaly and hydrocephaly arise from clastic ischaemic injury with dystrophic calcification and necrosis - and the spinal cord and brainstem lesions produce a fetal akinesia deformation sequence with neurogenic muscular atrophy, joint contractures and pterygia. The proliferative vasculopathy is confined to the CNS; it has never been observed outside it. What FLVCR2 actually transports is the live mechanistic question in this disease, and this entry curates it as one rather than resolving it. FLVCR2 is a major facilitator superfamily carrier expressed in brain endothelium. For over a decade the working model was heme import, from a 2010 demonstration that FLVCR2 mediates heme uptake and from structural modelling of patient alleles interpreted as stabilising an occluded conformation. In 2024 two independent structural and functional studies instead identified choline - and ethanolamine - as the physiological substrates, with FLVCR2 responsible for the majority of choline uptake into the brain across the blood-brain barrier. A patient allele has since been assayed directly against radiolabelled choline, and partial rather than complete transport loss was sufficient for disease. The two models are not simply successive: a 2026 retinal study revives a heme-dependent route through NOTCH tip/stalk specification, and the choline work itself splits on direction, with one group reading FLVCR2 as a luminal importer and another, from endothelial-specific knockouts with paradoxically raised brain choline, as an exporter of lysophosphatidylcholine-derived choline. The pathograph therefore carries both substrate arms as hypothesis groups converging on the same endothelial node. The disorder is almost invariably prenatally lethal and is usually detected on ultrasound between 13 and 27 weeks, though first-trimester recognition is documented. Survival is rare: across the systematic literature review, six of seventy-two reported patients lived beyond birth, with profound neurological disability and gross ventriculomegaly. There is no disease-modifying therapy.

Ask OpenScientist

Ask a research question about Fowler Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
10
Pathophys.
14
Phenotypes
2
Hypotheses
2
Gaps
24
Pathograph
1
Genes
3
Variants
1
Medical Actions
2
Models
👪

Inheritance

1
Autosomal recessive HP:0000007
Biallelic FLVCR2 variants. Affected sibships and consanguinity are both common: in one series of fourteen fetuses from ten families, sibs were affected in four families and the parents were consanguineous in six.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:20206334 SUPPORT Human Clinical
"is an autosomal-recessively inherited prenatal lethal disorder"
States the mode of inheritance.
PMID:20014121 SUPPORT Human Clinical
"In four families sibs were affected and in six the parents were consanguineous."
Documents the sibship recurrence and consanguinity consistent with recessive inheritance.
◈

Mechanistic Hypotheses

2
FLVCR2 Choline/Ethanolamine Transport Model
choline_transport_model CANONICAL
Evidence balance 3 support
FLVCR2 is a choline and ethanolamine carrier at the blood-brain barrier, selecting its substrates through cation-pi interactions in a conserved aromatic pocket. Disease alleles disrupt that transport, constraining the brain's supply of a nutrient it cannot make for itself, and the developing CNS vasculature fails. This is the current physiological account, established in 2024 by independent structural and functional work, and it is the model against which a clinical allele has been assayed directly.
Pathograph links
Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane -> Failure of Brain Choline Supply DIRECT Under the choline model, loss of FLVCR2 transport competence deprives the developing brain of the choline it cannot synthesise de novo and must import across the blood-brain barrier.
Failure of Brain Choline Supply -> CNS Endothelial Angiogenic Dysfunction INDIRECT UNKNOWN INTERMEDIATES How a constrained choline supply translates into defective CNS angiogenesis is not established. The transport defect and the angiogenic failure are each demonstrated, but no intermediate has been shown to connect them in patient or model tissue, so the edge is curated with unknown intermediates rather than as a mechanism.
Show evidence (3 references)
PMID:38693257 SUPPORT Model Organism
"Here we demonstrate both in vivo and in vitro that FLVCR2 is a BBB choline transporter and is responsible for the majority of choline uptake into the brain."
The primary demonstration that FLVCR2 is the blood-brain-barrier choline transporter.
PMID:38778100 SUPPORT In Vitro
"Here, we show that FLVCR1 and FLVCR2 facilitate the transport of choline and ethanolamine across the plasma membrane, using a concentration-driven substrate translocation process."
Independent structural and biochemical identification of the substrates.
PMID:40133703 SUPPORT In Vitro
"Our findings suggest that FLVCR2 deficiency may be sufficient to cause PVHH even in the absence of a complete loss of transport activity, possibly involving extragenetic factors in the pathophysiology of this complex condition."
Applies the model to a patient allele and finds partial transport loss sufficient, while flagging that extragenetic factors are likely involved.
FLVCR2 Heme-Import Model
heme_import_model ALTERNATIVE
Evidence balance 2 support 1 refute
The original account, in which FLVCR2 imports heme and disease alleles produce an endothelial heme deficit. It was the field's working model from 2010 and was supported by structural interpretation of the patient mutation set, but it was never demonstrated in patient tissue and the 2024 substrate work states that conclusive evidence for it never existed. It is retained as ALTERNATIVE rather than DEPRECATED because endothelial heme content remains a measured, manipulable variable with a mechanistic route to the angiogenic phenotype: reducing it de-represses NOTCH and perturbs tip/stalk specification, and heme precursor or hemin reverses that.
Pathograph links
Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane -> Reduced Endothelial Heme Availability INDIRECT UNKNOWN INTERMEDIATES Under the older heme model, the same alleles reduce heme import into endothelium. The edge is curated with unknown intermediates because the human evidence is structural inference over patient mutations rather than a measured heme deficit in patient tissue.
Reduced Endothelial Heme Availability -> CNS Endothelial Angiogenic Dysfunction INDIRECT KNOWN INTERMEDIATES In retinal endothelium, reduced heme content de-represses NOTCH signalling and drives hyperproliferation, and adding a heme precursor or cell-permeable hemin reverses it. The named intermediate is NOTCH1 activation acting on tip/stalk specification.
Show evidence (3 references)
PMID:20823265 SUPPORT In Vitro
"Here, we report the cellular function of FLVCR2 as an importer of heme, based on the following observations."
The study that established the heme-import model.
PMID:42429482 SUPPORT Model Organism
"Collectively, these data indicate a newly identified role for FLVCR2 and heme in the regulation of tip/stalk specification in angiogenesis."
Recent in vivo work sustaining a heme-dependent route to the angiogenic phenotype.
PMID:38778100 REFUTE In Vitro
"Earlier studies concluded that FLVCR1 may function as a haem exporter8-12, whereas FLVCR2 was suggested to act as a haem importer13, yet conclusive biochemical and detailed molecular evidence remained elusive for the function of both transporters14-16."
States that the biochemical basis for the heme-import assignment was never conclusive.
?

Discussions and Knowledge Gaps

2
Does FLVCR2 import choline into the brain across the blood-brain barrier, export lysophosphatidylcholine-derived choline out of it, or act principally as a heme importer - and which of these, if any, is the step whose failure causes the vasculopathy?
CONTROVERSY OPEN flvcr2_transport_direction_and_substrate
Attached to
pathophysiology#Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane mechanistic_hypotheses#choline_transport_model mechanistic_hypotheses#heme_import_model
Three readings of the same protein are live in the literature at once, and they are not simply a chronological succession. The 2010 heme-import assignment rested on binding, uptake, knockdown and toxicity experiments in cells, and structural analysis of patient alleles was later read as supporting it; the 2024 structural work states that conclusive evidence for it never existed and identifies choline and ethanolamine as the physiological substrates. But the two 2024 choline papers disagree with each other on direction: one demonstrates FLVCR2 as the blood-brain barrier choline importer responsible for most brain choline uptake, while the other, from endothelial-specific knockouts, finds brain choline paradoxically increased and concludes the carrier exports lysophosphatidylcholine-derived choline instead. And a 2026 retinal study revives heme as the operative variable, with a rescue arm. This entry therefore does not pick a winner: both substrate arms are curated as hypothesis groups converging on one endothelial node, and the causal edges from either substrate to the angiogenic defect are marked with unknown or named intermediates rather than asserted as mechanism.
Proposed experiments
Directional choline flux across patient-genotype brain endothelium
exp_flvcr2_directional_flux_in_patient_derived_bbb
Build a blood-brain-barrier model from iPSC-derived brain microvascular endothelial cells carrying defined patient FLVCR2 genotypes, including the hypomorphic p.(Arg492Trp), and measure luminal-to-abluminal and abluminal-to-luminal choline flux separately with stable-isotope tracing. The published import and export claims were made in different systems, so measuring both directions in one human system with matched genotypes is the discriminating experiment.
Perturbations
Introduce patient FLVCR2 genotypes into iPSC-derived brain endothelium
pathophysiology#Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane
Readouts
Direction-resolved choline flux
pathophysiology#Failure of Brain Choline Supply
Would support
pathophysiology#Failure of Brain Choline Supply
Substrate rescue arms in an angiogenic assay of FLVCR2-deficient endothelium
exp_flvcr2_heme_vs_choline_rescue
In the same FLVCR2-deficient endothelial angiogenesis assay, compare rescue by heme precursor or cell-permeable hemin against rescue by choline or phosphatidylcholine supplementation. The heme rescue has been shown; the choline rescue has not been tested head to head against it, and whichever restores sprout organisation identifies the limiting substrate for the phenotype rather than for the transporter.
Perturbations
Heme precursor versus choline supplementation of FLVCR2-deficient endothelium
pathophysiology#Reduced Endothelial Heme Availability
Readouts
Restoration of organised sprouting and loss of glomeruloid formation
pathophysiology#CNS Endothelial Angiogenic Dysfunction
Would support
pathophysiology#Reduced Endothelial Heme Availability
Show evidence (2 references)
PMID:38302740 SUPPORT Model Organism
"Collectively, our work identifies MFSD7c as a choline exporter at the BBB and provides a foundation for future work to reveal the disease mechanisms of Fowler syndrome."
The export conclusion that sits against the import conclusion of the companion 2024 work.
PMID:38693257 REFUTE Model Organism
"Here we demonstrate both in vivo and in vitro that FLVCR2 is a BBB choline transporter and is responsible for the majority of choline uptake into the brain."
Graded REFUTE against the export reading: the same year, in the same protein, this study concludes FLVCR2 is the importer responsible for most brain choline uptake.
Why do a small minority of patients with biallelic FLVCR2 variants survive beyond birth, and what determines phenotype when genotype does not?
KNOWLEDGE GAP OPEN fowler_syndrome_survival_determinants
Attached to
progression#Survival beyond infancy with profound disability genetic#FLVCR2 variants
Six of seventy-two published patients survived beyond birth, and no clear genotype-phenotype correlation explains which. The decisive observation is intrafamilial: three siblings carrying identical compound heterozygous alleles diverged, two showing the fetal cerebral phenotype and one markedly milder. Since the alleles are the same, whatever separates them is not the FLVCR2 genotype. The functional work points the same way - a patient allele retaining a quarter to a third of transport activity still produced the disease, and the authors explicitly raise extragenetic factors. Candidates include modifier loci acting on choline or heme handling, stochastic variation in the timing of the angiogenic insult relative to the vulnerable window of brain development, and maternal nutritional choline supply - none tested.
Proposed experiments
Genome-wide modifier search across the surviving cohort
exp_fowler_survivor_modifier_search
Sequence and compare survivors against lethal cases matched on FLVCR2 genotype where possible, beginning with the discordant sibships that already exist in the literature, and test candidate modifiers in the choline and heme handling pathways. The discordant-sibling families are the highest-information available material because they hold the primary genotype constant.
Readouts
Modifier variants segregating with survival
genetic#FLVCR2 variants
Show evidence (2 references)
PMID:32333401 SUPPORT Human Clinical
"The third sibling has a surprisingly milder clinical and radiological phenotype, suggesting intrafamilial variability."
The intrafamilial discordance at constant genotype that this gap records.
PMID:40133703 SUPPORT In Vitro
"possibly involving extragenetic factors in the pathophysiology of this complex condition"
The authors' own statement that extragenetic factors are likely at work.
⚙

Pathophysiology

10
Biallelic FLVCR2 Loss of Function
Autozygosity mapping in three consanguineous families localised the disorder to chromosome 14q24.3, and direct sequencing of candidate genes in the interval found five different germline FLVCR2 mutations across five families. FLVCR2 is a transmembrane carrier of the major facilitator superfamily. Reported alleles are predominantly missense; structural analysis of the published set has been interpreted as stabilising an occluded conformation or causing misfolding, and one splice-region deletion has been shown by minigene assay to impair splicing of exon 5.
FLVCR2 hgnc:20105 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves FLVCR2 (hgnc:20105). hgnc:20105 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context variant_origin: GERMLINE functional_impact_category: PARTIAL_LOSS_OF_FUNCTION
Biallelic germline FLVCR2 variants, homozygous in consanguineous kindreds and compound heterozygous in others. Complete transport-null alleles are not required: a compound heterozygote carrying p.(Arg492Trp) retained roughly a quarter to a third of wild-type transport activity.
Downstream
Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane Missense and splice-region alleles reduce the amount or the transport competence of FLVCR2 at the endothelial plasma membrane.
Show evidence (2 references)
PMID:20206334 SUPPORT Human Clinical
"Direct sequencing of candidate genes within the target interval revealed five different germline mutations in FLVCR2 in five families with Fowler syndrome."
The gene-discovery study establishing biallelic FLVCR2 variants as the cause.
PMID:40133703 SUPPORT In Vitro
"The effects of the c.1124+3_1124+6del variant were investigated through a minigene assay, which showed impaired splicing of the exon 5 of FLVCR2."
Functional demonstration that a clinical splice-region allele disrupts FLVCR2 splicing.
Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane
FLVCR2 is expressed in the endothelial cells of brain blood vessels, and the murine ortholog Mfsd7c is an endothelial transporter whose loss causes brain angiogenic growth deficiency and lethality. This node is the convergence point of the disease and is deliberately stated in substrate-neutral terms: what the carrier moves is contested, and the two candidate substrates are modelled as separate downstream arms opting into distinct hypothesis groups. Patient missense alleles have been shown directly to abolish or reduce transport activity, and a hypomorphic allele retaining a quarter to a third of activity was still sufficient for disease, so the lesion is graded rather than all-or-none.
FLVCR2 Choline/Ethanolamine Transport Model FLVCR2 Heme-Import Model
brain microvascular endothelial cell CL:2000044 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves brain microvascular endothelial cell (CL:2000044). CL:2000044 is a cell type from the Cell Ontology.
FLVCR2 hgnc:20105 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves FLVCR2 (hgnc:20105). hgnc:20105 is a gene from the HUGO Gene Nomenclature Committee.
Downstream
Failure of Brain Choline Supply Under the choline model, loss of FLVCR2 transport competence deprives the developing brain of the choline it cannot synthesise de novo and must import across the blood-brain barrier. FLVCR2 Choline/Ethanolamine Transport Model
Reduced Endothelial Heme Availability Under the older heme model, the same alleles reduce heme import into endothelium. The edge is curated with unknown intermediates because the human evidence is structural inference over patient mutations rather than a measured heme deficit in patient tissue. FLVCR2 Heme-Import Model
Show evidence (2 references)
PMID:40133703 SUPPORT Model Organism
"The loss of the murine ortholog Mfsd7c, an endothelial transporter in brain blood vessels, causes brain angiogenic growth deficiency and lethality."
Establishes FLVCR2 as an endothelial transporter of brain vessels whose loss impairs brain angiogenesis.
PMID:38302740 SUPPORT In Vitro
"We also showed that several missense mutations identified in patients exhibiting Fowler syndrome had abolished or reduced choline transport activity."
Patient alleles are directly shown to impair FLVCR2 transport function.
Failure of Brain Choline Supply
Choline is required in large quantities for phosphatidylcholine synthesis, for betaine-dependent methylation and, in cholinergic neurons, for acetylcholine. The brain cannot synthesise it efficiently de novo and derives most of it from the circulation, so a blood-brain-barrier carrier defect constrains supply at its entry step. FLVCR1 and FLVCR2 select choline and ethanolamine through cation-pi interactions with conserved tryptophan and tyrosine residues, which is why the clinical missense alleles that line that pocket are transport-incompetent.
FLVCR2 Choline/Ethanolamine Transport Model
brain microvascular endothelial cell CL:2000044 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves brain microvascular endothelial cell (CL:2000044). CL:2000044 is a cell type from the Cell Ontology.
FLVCR2 hgnc:20105 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves FLVCR2 (hgnc:20105). hgnc:20105 is a gene from the HUGO Gene Nomenclature Committee.
choline transport GO:0015871 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased choline transport (GO:0015871). GO:0015871 is a biological process from the Gene Ontology. ↓ DECREASED
choline transmembrane transporter activity GO:0015220 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased choline transmembrane transporter activity (GO:0015220). GO:0015220 is a molecular function from the Gene Ontology. ↓ DECREASED
Animal models
Mfsd7c-null mouse Mouse partially recapitulates The knockout reproduces a brain-restricted disturbance of choline handling, which is the substrate-level claim of the node. It does not settle the direction of transport, and the brain choline concentration moved opposite to the direction a simple import failure predicts.
Downstream
CNS Endothelial Angiogenic Dysfunction How a constrained choline supply translates into defective CNS angiogenesis is not established. The transport defect and the angiogenic failure are each demonstrated, but no intermediate has been shown to connect them in patient or model tissue, so the edge is curated with unknown intermediates rather than as a mechanism. FLVCR2 Choline/Ethanolamine Transport Model
Show evidence (2 references)
PMID:38693257 SUPPORT BACKGROUND Other
"Despite the brain’s high demand for choline, it cannot be efficiently synthesised de novo3. Instead, the brain derives the majority of its choline from systemic circulation, most of which originates from dietary sources1,3."
States the dependence of the brain on imported choline that makes a carrier defect rate-limiting. The sentence is the paper's framing of established physiology rather than its own measurement, so it is graded OTHER and marked BACKGROUND.
PMID:38778100 SUPPORT In Vitro
"Fully conserved tryptophan and tyrosine residues form the binding pocket of both transporters and confer selectivity for choline and ethanolamine through cation-π interactions."
Defines the substrate-selectivity mechanism whose disruption by patient alleles this node depends on.
Reduced Endothelial Heme Availability
The original cellular function assigned to FLVCR2 was heme import: the protein binds hemin-conjugated agarose competitively, cells and oocytes expressing it take up more heme, siRNA knockdown reduces heme import, and overexpressing cells are more heme-toxicity-sensitive. That account was never shown in patient tissue and has been displaced as the physiological function by the 2024 choline work, but it has not been abandoned: endothelial heme content remains the measured variable in the retinal angiogenesis arm below.
FLVCR2 Heme-Import Model
endothelial cell CL:0000115 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves endothelial cell (CL:0000115). CL:0000115 is a cell type from the Cell Ontology.
FLVCR2 hgnc:20105 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves FLVCR2 (hgnc:20105). hgnc:20105 is a gene from the HUGO Gene Nomenclature Committee.
heme transmembrane transporter activity GO:0015232 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased heme transmembrane transporter activity (GO:0015232). GO:0015232 is a molecular function from the Gene Ontology. ↓ DECREASED
Downstream
CNS Endothelial Angiogenic Dysfunction In retinal endothelium, reduced heme content de-represses NOTCH signalling and drives hyperproliferation, and adding a heme precursor or cell-permeable hemin reverses it. The named intermediate is NOTCH1 activation acting on tip/stalk specification. FLVCR2 Heme-Import Model
Show evidence (2 references)
PMID:20823265 SUPPORT In Vitro
"Second, mammalian cells and Xenopus laevis oocytes expressing FLVCR2 display enhanced heme uptake."
The cell-based result behind the heme-import assignment this node represents.
PMID:38778100 REFUTE In Vitro
"Earlier studies concluded that FLVCR1 may function as a haem exporter8-12, whereas FLVCR2 was suggested to act as a haem importer13, yet conclusive biochemical and detailed molecular evidence remained elusive for the function of both transporters14-16."
The structural and biochemical study that displaced heme import as FLVCR2's physiological function, stating that the evidence for it was never conclusive.
CNS Endothelial Angiogenic Dysfunction
The primary cellular lesion is in the endothelium of the developing CNS vasculature, which fails to build an orderly vascular bed. Endothelial-specific deletion of Flvcr2 in mouse, or chemical inhibition of heme synthesis, reduces vascular expansion of both retinal plexuses and in a subset produces frankly abnormal vascular glomeruloids - the same lesion seen in human CNS. Mechanistically the defect sits at tip/stalk specification, with loss of FLVCR2 attenuating the normal restraint on NOTCH1 and on VEGF-induced proliferation.
brain microvascular endothelial cell CL:2000044 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves brain microvascular endothelial cell (CL:2000044). CL:2000044 is a cell type from the Cell Ontology. retinal blood vessel endothelial cell CL:0002585 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves retinal blood vessel endothelial cell (CL:0002585). CL:0002585 is a cell type from the Cell Ontology.
sprouting angiogenesis GO:0002040 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal sprouting angiogenesis (GO:0002040). GO:0002040 is a biological process from the Gene Ontology. ⚠ ABNORMAL endothelial tip cell fate specification GO:0097102 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal endothelial tip cell fate specification (GO:0097102). GO:0097102 is a biological process from the Gene Ontology. ⚠ ABNORMAL Notch signaling pathway GO:0007219 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated Notch signaling pathway (GO:0007219). GO:0007219 is a biological process from the Gene Ontology. ↕ DYSREGULATED
Animal models
Endothelial-specific Flvcr2 conditional knockout mouse Mouse recapitulates Endothelium-restricted loss of Flvcr2 produces reduced vascular expansion and, in a subset, abnormal vascular glomeruloids - the human lesion - establishing that the angiogenic defect does not require loss of the transporter in any other cell type.
Downstream
Deficient Pericyte Coverage of CNS Vessels Immunohistology of affected fetal CNS shows a drastic reduction in the pericyte marker smooth muscle actin against matched control, from which the authors infer a pericyte-dependent remodelling defect. Whether the pericyte deficit is caused by the endothelial lesion or is a parallel consequence is not established.
Glomeruloid Vascular Proliferation of CNS and Retinal Vessels Disordered endothelial proliferation and failed sprout organisation produce the glomeruloid lesion itself.
Show evidence (2 references)
PMID:42429482 SUPPORT Model Organism
"Endothelial cell-specific deletion of Flvcr2 or chemical inhibition of heme synthesis during post-natal retinal vascularization led to reduced vascular expansion in both primary (superficial) and secondary (deep) vascular plexuses, and a more severe but partially penetrant phenotype with..."
Shows endothelial-autonomous FLVCR2 loss produces impaired vascular expansion and glomeruloid formation.
PMID:42429482 SUPPORT Model Organism
"Furthermore, we found that FLVCR2/heme signaling attenuates NOTCH1 activation and affects downstream tip/stalk cell specification, while also preventing VEGF-induced proliferation."
Identifies the tip/stalk specification step as the cellular process FLVCR2 acts on.
Deficient Pericyte Coverage of CNS Vessels
Pericyte marker expression is drastically reduced in affected CNS vessels. The authors of the sixteen-fetus series propose that the pathogenesis of the vasculopathy is related to abnormal pericyte-dependent remodelling of the CNS vasculature during angiogenesis. This is a proposal from histology, not a demonstrated step, and is curated as such.
pericyte CL:0000669 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves pericyte (CL:0000669). CL:0000669 is a cell type from the Cell Ontology.
Downstream
Glomeruloid Vascular Proliferation of CNS and Retinal Vessels Proposed contribution of defective pericyte-dependent vascular remodelling to the glomeruloid lesion. Curated as a hypothesis-level edge.
Show evidence (1 reference)
PMID:19635601 SUPPORT Human Clinical
"Our studies has expanded the description of FS to additional phenotypes, that could be called Fowler-like syndromes and suggest that the pathogenesis of PGV may be related to abnormal pericyte-dependent remodelling of the CNS vasculature, during CNS angiogenesis."
States the pericyte-remodelling proposal, in the authors' own hedged terms.
Glomeruloid Vascular Proliferation of CNS and Retinal Vessels
The pathognomonic lesion. Perforating vessels become abnormally thickened and aberrant, forming glomeruloid tufts of poorly organised endothelium with inclusion-bearing endothelial cells, throughout the central nervous system and the retinal vasculature. It was present in all fourteen fetuses of one autopsy series, though with variable extent of CNS involvement, and a focal form confined to restricted CNS territories exists alongside the classical diffuse form. Its confinement to the CNS is diagnostically decisive: the typical proliferative vasculopathy has never been observed outside the central nervous system.
brain microvascular endothelial cell CL:2000044 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves brain microvascular endothelial cell (CL:2000044). CL:2000044 is a cell type from the Cell Ontology.
angiogenesis GO:0001525 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal angiogenesis (GO:0001525). GO:0001525 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Diffuse Clastic Ischemic Injury of the Developing CNS The disruptive impact of the vascular malformation on the developing central nervous system is the accepted route from lesion to brain destruction.
Abnormal retinal vascular morphology The same glomeruloid lesion involves the retinal vasculature.
Show evidence (3 references)
PMID:20014121 SUPPORT Human Clinical
"Histology of the brain showed the characteristic glomeruloid vascular proliferation of Fowler syndrome in all cases, but with variable extent of involvement of the central nervous system."
Establishes the lesion as universal in the reported series with variable extent.
PMID:20014121 SUPPORT Human Clinical
"The typical proliferative vasculopathy was never observed outside the central nervous system and karyotypes were normal in the 10 fetuses studied."
Establishes the CNS confinement of the vasculopathy asserted by this node.
PMID:20206334 SUPPORT Human Clinical
"glomeruloid vasculopathy of the central nervous system and retinal vessels"
Records the retinal vessels as the one non-brain site the lesion involves.
Diffuse Clastic Ischemic Injury of the Developing CNS
Brain tissue that formed is destroyed. Diffuse clastic ischaemic lesions with calcification involve the brainstem, basal ganglia and spinal cord; dystrophic calcification and necrosis were present in every case of the fourteen-fetus autopsy series. This is an encephaloclastic process secondary to the vasculopathy, not a primary failure of neural patterning, which is what distinguishes the entity from the malformative causes of hydranencephaly.
brain development GO:0007420 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal brain development (GO:0007420). GO:0007420 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Hydranencephaly Destruction of the cerebral mantle leaves a translucent membranous structure in place of cortex.
Hydrocephalus Ventricular dilatation accompanies or replaces the hydranencephalic picture.
Cerebral calcification Dystrophic calcification of the clastic lesions.
Spinal Cord and Brainstem Clastic Lesions with Neurogenic Muscular Atrophy The same clastic process involves the brainstem and spinal cord, and the lower motor neuron loss it produces is what denervates fetal muscle.
Show evidence (3 references)
PMID:20206334 SUPPORT Human Clinical
"brain stem, basal ganglia, and spinal cord diffuse clastic ischemic lesions with calcifications"
Names the distribution of the clastic ischaemic lesions this node represents.
PMID:20014121 SUPPORT Human Clinical
"Dystrophic calcification and necrosis were always present."
Establishes calcification and necrosis as invariable findings.
PMID:29500860 SUPPORT Human Clinical
"Subsequent reports have shown that hydranencephaly–hydrocephaly resulted from the destruction of brain tissue due to vascular anomalies, while other features were likely secondary to CNS injuries."
States the encephaloclastic mechanism and the secondary status of the extracranial features.
Spinal Cord and Brainstem Clastic Lesions with Neurogenic Muscular Atrophy
Involvement of the spinal cord and brainstem by the same clastic ischaemic process denervates fetal muscle, giving the muscular neurogenic atrophy that is part of the original phenotype definition. This is the node that converts a cerebrovascular disease into a fetal akinesia syndrome, and it is why Fowler syndrome belongs in the differential of lethal multiple pterygium syndrome rather than only in that of hydranencephaly.
motor neuron CL:0000100 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves motor neuron (CL:0000100). CL:0000100 is a cell type from the Cell Ontology.
Downstream
Fetal Akinesia Deformation Sequence Denervation abolishes fetal movement, and immobility in utero produces the deformation sequence.
Show evidence (1 reference)
PMID:20206334 SUPPORT Human Clinical
"a fetal akinesia deformation sequence (FADS) with muscular neurogenic atrophy"
Names the neurogenic muscular atrophy and the akinesia sequence this node produces.
Fetal Akinesia Deformation Sequence
Absent or reduced fetal movement produces a stereotyped deformation sequence: joint contractures, pterygia, micrognathia and postural abnormalities. In the fourteen-fetus series, joint contractures were present in twelve and pterygia in eleven, against micrognathia in ten. These are secondary mechanical consequences of immobility, not independent malformations, which is why they cluster so tightly with each other and so loosely with the severity of the cerebral lesion.
Downstream
Arthrogryposis multiplex congenita Joint contractures from restricted intrauterine movement.
Pterygium Webbing across immobilised joints.
Micrognathia Reduced mandibular growth from absent fetal jaw movement.
Decreased fetal movement The akinesia itself, as observed antenatally.
Show evidence (1 reference)
PMID:20014121 SUPPORT Human Clinical
"Extra-cranial anomalies included micrognathia (10 fetuses), cleft palate (1 fetus), cystic hygroma (2 fetuses), joint contractures (12 fetuses), and pterygia (11 fetuses)."
Quantifies the deformation-sequence features across the reported series.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Fowler Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

14
Cardiovascular 1
Abnormal retinal vascular morphology FREQUENT HP:0008046 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal retinal vascular morphology (HP:0008046). HP:0008046 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20206334 SUPPORT Human Clinical
"glomeruloid vasculopathy of the central nervous system and retinal vessels"
Records retinal vascular involvement in the phenotype definition.
Head and Neck 4
Micrognathia FREQUENT HP:0000347 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Micrognathia (HP:0000347). HP:0000347 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20014121 SUPPORT Human Clinical
"Extra-cranial anomalies included micrognathia (10 fetuses)"
Frequency of micrognathia in the series.
Cleft palate VERY_RARE HP:0000175 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cleft palate (HP:0000175). HP:0000175 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20014121 SUPPORT Human Clinical
"Extra-cranial anomalies included micrognathia (10 fetuses), cleft palate (1 fetus), cystic hygroma (2 fetuses), joint contractures (12 fetuses), and pterygia (11 fetuses)."
Records the single cleft palate in the series; the quoted sentence is the full extra-cranial tally the count sits inside.
Cystic hygroma OCCASIONAL HP:0000476 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cystic hygroma (HP:0000476). HP:0000476 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:12493052 SUPPORT Human Clinical
"The pregnancy with no significant family history was referred for karyotyping and ultrasound examination after a cystic hygroma was seen at 12 weeks."
Documents cystic hygroma as a first-trimester presenting sign.
Microcephaly FREQUENT HP:0000252 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Microcephaly (HP:0000252). HP:0000252 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:40133703 SUPPORT Human Clinical
"This often-lethal condition features microcephaly, skeletal deformities, and severe cerebrovascular defects."
Names microcephaly among the condition's features.
Integument 1
Pterygium VERY_FREQUENT HP:0001059 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pterygium (HP:0001059). HP:0001059 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20014121 SUPPORT Human Clinical
"Fowler syndrome should be considered in the differential diagnosis of lethal multiple pterygium syndrome, fetal akinesia, and hydrocephalus in addition to classical hydranencephaly."
States the differential-diagnostic significance of the pterygia.
Musculoskeletal 2
Cerebral calcification VERY_FREQUENT HP:0002514 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebral calcification (HP:0002514). HP:0002514 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20014121 SUPPORT Human Clinical
"Dystrophic calcification and necrosis were always present."
Calcification was present in every case of the series.
Arthrogryposis multiplex congenita VERY_FREQUENT HP:0002804 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Arthrogryposis multiplex congenita (HP:0002804). HP:0002804 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20014121 SUPPORT Human Clinical
"joint contractures (12 fetuses), and pterygia (11 fetuses)"
Frequency of contractures and pterygia in the autopsy series.
Nervous System 5
Hydranencephaly VERY_FREQUENT HP:0002324 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hydranencephaly (HP:0002324). HP:0002324 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20014121 SUPPORT Human Clinical
"At autopsy the cerebral cortex appeared as a translucent membranous structure (hydranencephaly) in most fetuses."
Establishes hydranencephaly as the usual autopsy finding.
Hydrocephalus VERY_FREQUENT HP:0000238 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hydrocephalus (HP:0000238). HP:0000238 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20014121 SUPPORT Human Clinical
"Antenatal ultrasonography showed hydrocephaly in all except two fetuses"
Frequency of antenatal hydrocephaly in the reported series.
Ventriculomegaly FREQUENT HP:0002119 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ventriculomegaly (HP:0002119). HP:0002119 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32333401 SUPPORT Human Clinical
"it is important to consider Fowler syndrome in patients with gross ventriculomegaly, cortical malformations and/or cerebral calcifications on brain imaging."
States the postnatal imaging presentation that should raise the diagnosis.
Cerebellar hypoplasia OCCASIONAL HP:0001321 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebellar hypoplasia (HP:0001321). HP:0001321 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25677735 SUPPORT Human Clinical
"profound ventriculomegaly with only a thin edging of the cerebral cortex and hypoplastic cerebellum"
Records cerebellar hypoplasia in genetically confirmed survivors.
Seizure OCCASIONAL HP:0001250 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Seizure (HP:0001250). HP:0001250 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25677735 SUPPORT Human Clinical
"severe intellectual and neurologic disability with seizures, absence of functional movements, and no means of communication"
Documents seizures in the survivors.
Prenatal and Birth 1
Decreased fetal movement VERY_FREQUENT HP:0001558 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Decreased fetal movement (HP:0001558). HP:0001558 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25677735 SUPPORT Human Clinical
"Hallmarks of the syndrome are glomerular vasculopathy in the central nervous system, severe hydrocephaly, hypokinesia and arthrogryphosis."
Lists hypokinesia as a hallmark.
🧬

Genetic Associations

1
FLVCR2 variants
Gene: FLVCR2 hgnc:20105 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is FLVCR2 (hgnc:20105). hgnc:20105 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Autosomal recessive
Show evidence (2 references)
PMID:29500860 SUPPORT Human Clinical
"The present report confirms the genetic homogeneity of Fowler syndrome and describes a new FLVCR2 mutation affecting the protein function."
States the genetic homogeneity of the disorder.
PMID:32333401 SUPPORT Human Clinical
"Although no clear phenotype-genotype correlation exists, some variants appear to be associated with a less severe phenotype compatible with life."
States the absence of a clear genotype-phenotype correlation.
Variants (3)
Homozygous FLVCR2 c.1289C>T
The allele in the first reported patients to survive beyond infancy, a brother and sister homozygous for it, identified by whole-exome sequencing.
Show evidence (1 reference)
PMID:25677735 SUPPORT Human Clinical
"Investigation with whole-exome sequencing (WES) revealed, in both patients, a homozygous pathogenic mutation in FLVCR2, c.1289C>T, compatible with a diagnosis of Fowler syndrome."
Names the allele and the method by which it was found.
Compound heterozygous c.327T>A (p.Asn109Lys) and c.887C>T (p.Ser296Leu)
Shared by three siblings who survived into adulthood, two with the cerebral features seen in affected fetuses and one considerably milder - the clearest published demonstration that genotype does not fix phenotype in this disease.
Show evidence (1 reference)
PMID:32333401 SUPPORT Human Clinical
"Although our three patients carry the same mutations (c.327T>A-p.Asn109Lys and c.887C>T-p.Ser296Leu) in FLVCR2, only two of them presented with the same cerebral features, ventriculomegaly and cerebral calcifications, as affected fetuses."
Names the alleles and documents the intrafamilial discordance.
Compound heterozygous c.1124+3_1124+6del and p.(Arg492Trp)
A fetal case in which both alleles were functionally characterised: the splice variant impairs exon 5 splicing on minigene assay, and p.(Arg492Trp) was modelled as highly destabilising and shown to cut transport activity by half, leaving net activity of a quarter to a third.
Show evidence (1 reference)
PMID:40133703 SUPPORT Human Clinical
"Through exome sequencing, we identified two compound heterozygous FLVCR2 variants: the maternal c.1124+3_1124+6del and the paternal p.(Arg492Trp)."
Names the two alleles in the functionally characterised fetal case.
💊

Medical Actions

1
Genetic counseling and recurrence-risk assessment
Action: genetic counselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is genetic counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. Ontology label: Genetic Counseling NCIT:C15240
Platform: Behavioral / lifestyle
There is no disease-modifying therapy. Management is prenatal diagnosis, counselling about the autosomal recessive recurrence risk, and discussion of options; several reported pregnancies ended in termination. Distinguishing Fowler syndrome at autopsy from other causes of hydrocephaly and hydranencephaly matters precisely because it carries a one-in-four recurrence risk where those other causes may not.
Show evidence (1 reference)
PMID:12493052 SUPPORT Human Clinical
"The diagnosis of proliferative vasculopathy and hydrocephaly-hydranencephaly (Fowler syndrome) should be considered whenever hydrocephaly-hydranencephaly associated with a fetal akinetic sequence are encountered at the end of the first trimester. Genetic counseling is recommended."
The closing sentence recommends genetic counselling, which is the management this entry records. The diagnostic trigger in the same quote is carried by the prenatal-ultrasound item under diagnosis.
🔬

Diagnosis

3
Prenatal ultrasound
Fowler syndrome is usually first suspected on fetal imaging. Hydrocephaly or hydranencephaly together with a fetal akinesia deformation sequence, detectable from the end of the first trimester, is the trigger to consider the diagnosis. Imaging raises the suspicion; it does not establish the diagnosis, which rests on neuropathology or molecular testing.
prenatal ultrasound imaging NCIT:C17230 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:12493052 SUPPORT Human Clinical
"The diagnosis of proliferative vasculopathy and hydrocephaly-hydranencephaly (Fowler syndrome) should be considered whenever hydrocephaly-hydranencephaly associated with a fetal akinetic sequence are encountered at the end of the first trimester. Genetic counseling is recommended."
States the sonographic trigger and the gestational age at which it becomes apparent, which is what makes ultrasound the entry point to the diagnostic pathway.
Neuropathological examination at autopsy
Autopsy with examination of the brain is what distinguishes Fowler syndrome from the other causes of hydrocephaly and hydranencephaly, by demonstrating the glomeruloid vasculopathy and diffuse clastic ischemic lesions. Because those other causes may carry a lower recurrence risk than this disorder's one-in-four, the distinction changes the counselling given for the next pregnancy.
autopsy NCIT:C25153 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:20014121 SUPPORT Human Clinical
"Autopsy and study of the brain are essential to differentiate autosomal recessive Fowler syndrome from other causes of hydrocephaly and hydranencephaly, which may have a lower recurrence risk."
States that autopsy is essential to differentiate this disorder, and gives the recurrence-risk reason the differentiation matters.
FLVCR2 molecular genetic testing
Identification of biallelic FLVCR2 variants confirms the diagnosis molecularly and is what allows recurrence-risk counselling and prenatal or preimplantation testing in a subsequent pregnancy without relying on autopsy of an affected fetus.
FLVCR2 sequencing NCIT:C19770 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:20206334 SUPPORT INDIRECT Human Clinical
"Direct sequencing of candidate genes within the target interval revealed five different germline mutations in FLVCR2 in five families with Fowler syndrome."
Establishes FLVCR2 sequencing as the route to a molecular diagnosis. INDIRECT because the paper reports gene discovery in five families rather than evaluating sequencing as a diagnostic test, so its sensitivity in unselected cases is not addressed here.
📈

Progression

3
Prenatal detection
Detection is usually by second-trimester ultrasound, between 13 and 27 weeks of gestation. First-trimester recognition is documented: in one pregnancy referred for a cystic hygroma at 12 weeks, ultrasound at 13 weeks already showed hydrocephaly-hydranencephaly with fetal akinesia and arthrogryposis.
Show evidence (2 references)
PMID:29500860 SUPPORT Human Clinical
"The disorder is almost invariably prenatally lethal, usually detected by ultrasound between the 13 and 27 weeks of gestation"
States the usual gestational window of prenatal detection.
PMID:12493052 SUPPORT Human Clinical
"At 13 weeks, ultrasound examination revealed hydrocephaly-hydranencephaly, fetal akinesia, and arthrogryposis associated with increased nuchal translucency."
Documents first-trimester recognition of the full phenotype.
Prenatal or perinatal lethality
The syndrome has long been regarded as prenatally lethal, and the great majority of reported patients die before or around birth.
Show evidence (1 reference)
PMID:32333401 SUPPORT Human Clinical
"Only 6/72 (8%) survived beyond birth."
Quantifies the fraction of reported patients surviving past birth.
Survival beyond infancy with profound disability
A minority survive. The first reported survivors, a brother and sister homozygous for FLVCR2 c.1289C>T, had severe intellectual and neurological disability with seizures, no functional movement and no means of communication, on a background of profound ventriculomegaly, calcifications and cerebellar hypoplasia. Intrafamilial variability is documented: of three siblings carrying identical alleles, only two showed the cerebral features seen in affected fetuses.
Show evidence (2 references)
PMID:25677735 SUPPORT Human Clinical
"The patients present a phenotype of severe intellectual and neurologic disability with seizures, absence of functional movements, and no means of communication."
Describes the clinical course in the first documented survivors beyond infancy.
PMID:32333401 SUPPORT Human Clinical
"The third sibling has a surprisingly milder clinical and radiological phenotype, suggesting intrafamilial variability."
Documents intrafamilial variability among siblings sharing the same genotype.
📊

Prevalence

1
Worldwide
Cases In Literature <1 in 1,000,000
Ultra-rare. A 2020 systematic review of thirty articles counted sixty-nine published patients and, including its own three, seventy-two in total. No population-based estimate exists, so the published case count is the meaningful figure and no numeric rate is asserted.
Show evidence (1 reference)
PMID:32333401 SUPPORT Human Clinical
"Thirty articles were included, describing 69 individual patients. To date, including our clinical reports, 72 patients have been described with Fowler syndrome."
Gives the worldwide published case count behind the ultra-rare class asserted here.
🐁

Animal Models

2
Mfsd7c-null mouse
Constitutive knockout of the murine FLVCR2 ortholog. Metabolomics of knockout embryos shows choline-related metabolites altered in brain but not liver, which is what localises the defect to the blood-brain barrier rather than to systemic choline handling. The model is also the source of the directionality problem curated below: endothelial-specific deletion suppressed import of exogenous choline from blood yet raised brain choline, and stable-isotope tracing implicated the carrier in exporting lysophosphatidylcholine-derived choline instead.
Species
Mouse
Genotype
Mfsd7c knockout (Mfsd7c-/-)
Genes
FLVCR2 hgnc:20105 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns FLVCR2 (hgnc:20105). hgnc:20105 is a gene from the HUGO Gene Nomenclature Committee.
Publication
PMID:38302740
Pathograph links
Failure of Brain Choline Supply partially recapitulates fidelity: moderate observes: molecular The knockout reproduces a brain-restricted disturbance of choline handling, which is the substrate-level claim of the node. It does not settle the direction of transport, and the brain choline concentration moved opposite to the direction a simple import failure predicts.
Limitations: Mouse, and constitutive rather than allele-matched to any patient genotype. The central discrepancy is unresolved within the model itself: brain choline rose rather than fell on endothelial deletion, so the model supports a choline-handling defect without supporting brain choline deficiency as such.
Readouts
Brain choline-related metabolite profile
Direction: ALTERED
Interpretation: Choline-related metabolites are altered in knockout brain but not liver, localising the transport defect to the blood-brain barrier.
Show evidence (1 reference)
PMID:38302740 SUPPORT Model Organism
"Particularly, we found that choline-related metabolites were altered in the brains but not in the livers of Mfsd7c-/- embryos."
The measurement grounding this readout and its tissue specificity.
Brain choline concentration after endothelial-specific deletion
Direction: INCREASED
Interpretation: A negative result for the simple import model: suppressing blood-derived choline import raised rather than lowered brain choline.
Show evidence (1 reference)
PMID:38302740 REFUTE Model Organism
"Mice lacking Mfsd7c in endothelial cells of the central nervous system suppressed the import of exogenous choline from blood but unexpectedly had increased choline levels in the brain."
Quantified in the direction opposite to that predicted by a pure import failure, which is why it is graded REFUTE against this node's claim.
Show evidence (1 reference)
PMID:38302740 SUPPORT Model Organism
"Here, we used Mfsd7c knockout (Mfsd7c-/-) mice and cell-based assays to reveal that MFSD7c is a choline transporter at the blood-brain barrier (BBB)."
Establishes the model and what it is informative for.
Endothelial-specific Flvcr2 conditional knockout mouse
Conditional deletion restricted to endothelium, assayed during post-natal retinal vascularization. It is the cleanest available demonstration that the angiogenic defect is endothelium-autonomous, and it reproduces the glomeruloid lesion itself in a tissue that can be imaged whole-mount.
Species
Mouse
Genotype
Endothelial cell-specific Flvcr2 conditional knockout
Genes
FLVCR2 hgnc:20105 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns FLVCR2 (hgnc:20105). hgnc:20105 is a gene from the HUGO Gene Nomenclature Committee.
Publication
PMID:42429482
Pathograph links
CNS Endothelial Angiogenic Dysfunction recapitulates fidelity: moderate observes: cellular Endothelium-restricted loss of Flvcr2 produces reduced vascular expansion and, in a subset, abnormal vascular glomeruloids - the human lesion - establishing that the angiogenic defect does not require loss of the transporter in any other cell type.
Limitations: The vascular bed is retina rather than brain, and the timing is post-natal rather than the mid-gestation window in which the human disease destroys the brain. The severe phenotype is partially penetrant.
Readouts
Retinal vascular plexus expansion
Direction: DECREASED
Interpretation: Reduced angiogenic outgrowth in both superficial and deep plexuses.
Show evidence (1 reference)
PMID:42429482 SUPPORT Model Organism
"led to reduced vascular expansion in both primary (superficial) and secondary (deep) vascular plexuses"
The quantified angiogenic deficit behind this readout.
Show evidence (1 reference)
PMID:42429482 SUPPORT Model Organism
"Here, we use conditional knockout of Flvcr2 in mice and knockdown in primary bovine retinal endothelial cell culture to explore retinal development and associated mechanisms of angiogenic regulation by FLVCR2."
Establishes the model system and its purpose.
{ }

Source YAML

click to show 
name: Fowler Syndrome
category: Mendelian
creation_date: '2026-09-15T00:00:00Z'
synonyms:
- Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome
- PVHH
- Cerebral proliferative glomeruloid vasculopathy
- Encephaloclastic proliferative vasculopathy
- Hydrocephaly-hydranencephaly proliferative vasculopathy
description: >
  An autosomal recessive disorder of central nervous system angiogenesis caused by
  biallelic variants in FLVCR2, delineated by Fowler in 1972 as a stereotyped lethal
  fetal phenotype and molecularly solved in 2010. The defining lesion is not a
  malformation of brain tissue but of the vessels that supply it: abnormally
  thickened, aberrant perforating vessels form glomeruloids of poorly organised
  endothelium throughout the CNS and retina. Everything else follows from that
  vasculopathy. The brain is destroyed rather than mis-built - hydranencephaly and
  hydrocephaly arise from clastic ischaemic injury with dystrophic calcification and
  necrosis - and the spinal cord and brainstem lesions produce a fetal akinesia
  deformation sequence with neurogenic muscular atrophy, joint contractures and
  pterygia. The proliferative vasculopathy is confined to the CNS; it has never been
  observed outside it.

  What FLVCR2 actually transports is the live mechanistic question in this disease,
  and this entry curates it as one rather than resolving it. FLVCR2 is a major
  facilitator superfamily carrier expressed in brain endothelium. For over a decade
  the working model was heme import, from a 2010 demonstration that FLVCR2 mediates
  heme uptake and from structural modelling of patient alleles interpreted as
  stabilising an occluded conformation. In 2024 two independent structural and
  functional studies instead identified choline - and ethanolamine - as the
  physiological substrates, with FLVCR2 responsible for the majority of choline
  uptake into the brain across the blood-brain barrier. A patient allele has since
  been assayed directly against radiolabelled choline, and partial rather than
  complete transport loss was sufficient for disease. The two models are not simply
  successive: a 2026 retinal study revives a heme-dependent route through NOTCH
  tip/stalk specification, and the choline work itself splits on direction, with one
  group reading FLVCR2 as a luminal importer and another, from endothelial-specific
  knockouts with paradoxically raised brain choline, as an exporter of
  lysophosphatidylcholine-derived choline. The pathograph therefore carries both
  substrate arms as hypothesis groups converging on the same endothelial node.

  The disorder is almost invariably prenatally lethal and is usually detected on
  ultrasound between 13 and 27 weeks, though first-trimester recognition is
  documented. Survival is rare: across the systematic literature review, six of
  seventy-two reported patients lived beyond birth, with profound neurological
  disability and gross ventriculomegaly. There is no disease-modifying therapy.
disease_term:
  preferred_term: Fowler syndrome
  term:
    id: MONDO:0009168
    label: Fowler syndrome
parents:
- Inherited Cerebrovascular Disorder
- Fetal Akinesia Deformation Sequence Disorder
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: BELOW_1_IN_1000000
  notes: >
    Ultra-rare. A 2020 systematic review of thirty articles counted sixty-nine
    published patients and, including its own three, seventy-two in total. No
    population-based estimate exists, so the published case count is the
    meaningful figure and no numeric rate is asserted.
  evidence:
  - reference: PMID:32333401
    reference_title: "Expanding the clinical spectrum of Fowler syndrome: Three siblings with survival into adulthood and systematic review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thirty articles were included, describing 69 individual patients. To date, including our clinical reports, 72 patients have been described with Fowler syndrome."
    explanation: Gives the worldwide published case count behind the ultra-rare class asserted here.
progression:
- phase: Prenatal detection
  notes: >
    Detection is usually by second-trimester ultrasound, between 13 and 27 weeks of
    gestation. First-trimester recognition is documented: in one pregnancy referred
    for a cystic hygroma at 12 weeks, ultrasound at 13 weeks already showed
    hydrocephaly-hydranencephaly with fetal akinesia and arthrogryposis.
  evidence:
  - reference: PMID:29500860
    reference_title: "Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome or Fowler syndrome: Report of a family and insight into the disease's mechanism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The disorder is almost invariably prenatally lethal, usually detected by ultrasound between the 13 and 27 weeks of gestation"
    explanation: States the usual gestational window of prenatal detection.
  - reference: PMID:12493052
    reference_title: First-trimester features of Fowler syndrome (hydrocephaly-hydranencephaly proliferative vasculopathy).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At 13 weeks, ultrasound examination revealed hydrocephaly-hydranencephaly, fetal akinesia, and arthrogryposis associated with increased nuchal translucency."
    explanation: Documents first-trimester recognition of the full phenotype.
- phase: Prenatal or perinatal lethality
  notes: >
    The syndrome has long been regarded as prenatally lethal, and the great majority
    of reported patients die before or around birth.
  evidence:
  - reference: PMID:32333401
    reference_title: "Expanding the clinical spectrum of Fowler syndrome: Three siblings with survival into adulthood and systematic review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Only 6/72 (8%) survived beyond birth."
    explanation: Quantifies the fraction of reported patients surviving past birth.
- phase: Survival beyond infancy with profound disability
  notes: >
    A minority survive. The first reported survivors, a brother and sister homozygous
    for FLVCR2 c.1289C>T, had severe intellectual and neurological disability with
    seizures, no functional movement and no means of communication, on a background of
    profound ventriculomegaly, calcifications and cerebellar hypoplasia. Intrafamilial
    variability is documented: of three siblings carrying identical alleles, only two
    showed the cerebral features seen in affected fetuses.
  evidence:
  - reference: PMID:25677735
    reference_title: Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patients present a phenotype of severe intellectual and neurologic disability with seizures, absence of functional movements, and no means of communication."
    explanation: Describes the clinical course in the first documented survivors beyond infancy.
  - reference: PMID:32333401
    reference_title: "Expanding the clinical spectrum of Fowler syndrome: Three siblings with survival into adulthood and systematic review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The third sibling has a surprisingly milder clinical and radiological phenotype, suggesting intrafamilial variability."
    explanation: Documents intrafamilial variability among siblings sharing the same genotype.
pathophysiology:
- name: Biallelic FLVCR2 Loss of Function
  biological_scale: MOLECULAR
  description: >
    Autozygosity mapping in three consanguineous families localised the disorder to
    chromosome 14q24.3, and direct sequencing of candidate genes in the interval found
    five different germline FLVCR2 mutations across five families. FLVCR2 is a
    transmembrane carrier of the major facilitator superfamily. Reported alleles are
    predominantly missense; structural analysis of the published set has been
    interpreted as stabilising an occluded conformation or causing misfolding, and one
    splice-region deletion has been shown by minigene assay to impair splicing of
    exon 5.
  genes:
  - preferred_term: FLVCR2
    term:
      id: hgnc:20105
      label: FLVCR2
  genetic_context:
    description: >
      Biallelic germline FLVCR2 variants, homozygous in consanguineous kindreds and
      compound heterozygous in others. Complete transport-null alleles are not
      required: a compound heterozygote carrying p.(Arg492Trp) retained roughly a
      quarter to a third of wild-type transport activity.
    functional_impact_category: PARTIAL_LOSS_OF_FUNCTION
    variant_origin: GERMLINE
  evidence:
  - reference: PMID:20206334
    reference_title: Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Direct sequencing of candidate genes within the target interval revealed five different germline mutations in FLVCR2 in five families with Fowler syndrome."
    explanation: The gene-discovery study establishing biallelic FLVCR2 variants as the cause.
  - reference: PMID:40133703
    reference_title: A hypomorphic FLVCR2 variant resulting in moderate transport deficiency causes hydranencephaly syndrome with brain calcifications.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The effects of the c.1124+3_1124+6del variant were investigated through a minigene assay, which showed impaired splicing of the exon 5 of FLVCR2."
    explanation: Functional demonstration that a clinical splice-region allele disrupts FLVCR2 splicing.
  downstream:
  - target: Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane
    causal_link_type: DIRECT
    description: >
      Missense and splice-region alleles reduce the amount or the transport competence
      of FLVCR2 at the endothelial plasma membrane.
    evidence:
    - reference: PMID:40133703
      reference_title: A hypomorphic FLVCR2 variant resulting in moderate transport deficiency causes hydranencephaly syndrome with brain calcifications.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "we performed a radiolabeled-choline or ethanolamine transport assays in HEK 293 cells and found that the p.(Arg492Trp) variant causes a 50-60% reduction of FLVCR2 transport activity, resulting in a net activity of 25-30%."
      explanation: Quantifies the transport deficit a clinical FLVCR2 allele produces.
- name: Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane
  biological_scale: MOLECULAR
  description: >
    FLVCR2 is expressed in the endothelial cells of brain blood vessels, and the
    murine ortholog Mfsd7c is an endothelial transporter whose loss causes brain
    angiogenic growth deficiency and lethality. This node is the convergence point of
    the disease and is deliberately stated in substrate-neutral terms: what the
    carrier moves is contested, and the two candidate substrates are modelled as
    separate downstream arms opting into distinct hypothesis groups. Patient missense
    alleles have been shown directly to abolish or reduce transport activity, and a
    hypomorphic allele retaining a quarter to a third of activity was still sufficient
    for disease, so the lesion is graded rather than all-or-none.
  genes:
  - preferred_term: FLVCR2
    term:
      id: hgnc:20105
      label: FLVCR2
  cell_types:
  - preferred_term: brain microvascular endothelial cell
    term:
      id: CL:2000044
      label: brain microvascular endothelial cell
  evidence:
  - reference: PMID:40133703
    reference_title: A hypomorphic FLVCR2 variant resulting in moderate transport deficiency causes hydranencephaly syndrome with brain calcifications.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The loss of the murine ortholog Mfsd7c, an endothelial transporter in brain blood vessels, causes brain angiogenic growth deficiency and lethality."
    explanation: Establishes FLVCR2 as an endothelial transporter of brain vessels whose loss impairs brain angiogenesis.
  - reference: PMID:38302740
    reference_title: MFSD7c functions as a transporter of choline at the blood-brain barrier.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We also showed that several missense mutations identified in patients exhibiting Fowler syndrome had abolished or reduced choline transport activity."
    explanation: Patient alleles are directly shown to impair FLVCR2 transport function.
  downstream:
  - target: Failure of Brain Choline Supply
    causal_link_type: DIRECT
    hypothesis_groups:
    - choline_transport_model
    description: >
      Under the choline model, loss of FLVCR2 transport competence deprives the
      developing brain of the choline it cannot synthesise de novo and must import
      across the blood-brain barrier.
    evidence:
    - reference: PMID:38693257
      reference_title: Structural and molecular basis of choline uptake into the brain by FLVCR2.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Here we demonstrate both in vivo and in vitro that FLVCR2 is a BBB choline transporter and is responsible for the majority of choline uptake into the brain."
      explanation: Establishes the substrate and the transport step this edge asserts.
  - target: Reduced Endothelial Heme Availability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - heme_import_model
    description: >
      Under the older heme model, the same alleles reduce heme import into endothelium.
      The edge is curated with unknown intermediates because the human evidence is
      structural inference over patient mutations rather than a measured heme deficit
      in patient tissue.
    evidence:
    - reference: PMID:29500860
      reference_title: "Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome or Fowler syndrome: Report of a family and insight into the disease's mechanism."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: "The structural analysis of the present and previously published FLVCR2 mutations supports the hypothesis of a reduced heme import as the underlying disease's mechanism due to the stabilization of the occluded conformation or a protein misfolding."
      explanation: States the heme-import model and the structural reasoning it rests on.
- name: Failure of Brain Choline Supply
  biological_scale: MOLECULAR
  description: >
    Choline is required in large quantities for phosphatidylcholine synthesis, for
    betaine-dependent methylation and, in cholinergic neurons, for acetylcholine. The
    brain cannot synthesise it efficiently de novo and derives most of it from the
    circulation, so a blood-brain-barrier carrier defect constrains supply at its entry
    step. FLVCR1 and FLVCR2 select choline and ethanolamine through cation-pi
    interactions with conserved tryptophan and tyrosine residues, which is why the
    clinical missense alleles that line that pocket are transport-incompetent.
  genes:
  - preferred_term: FLVCR2
    term:
      id: hgnc:20105
      label: FLVCR2
  molecular_functions:
  - preferred_term: choline transmembrane transporter activity
    term:
      id: GO:0015220
      label: choline transmembrane transporter activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: choline transport
    term:
      id: GO:0015871
      label: choline transport
    modifier: DECREASED
  cell_types:
  - preferred_term: brain microvascular endothelial cell
    term:
      id: CL:2000044
      label: brain microvascular endothelial cell
  evidence:
  - reference: PMID:38693257
    reference_title: Structural and molecular basis of choline uptake into the brain by FLVCR2.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: BACKGROUND
    snippet: "Despite the brain’s high demand for choline, it cannot be efficiently synthesised de novo3. Instead, the brain derives the majority of its choline from systemic circulation, most of which originates from dietary sources1,3."
    explanation: >-
      States the dependence of the brain on imported choline that makes a carrier
      defect rate-limiting. The sentence is the paper's framing of established
      physiology rather than its own measurement, so it is graded OTHER and marked
      BACKGROUND.
  - reference: PMID:38778100
    reference_title: Molecular mechanism of choline and ethanolamine transport in humans.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Fully conserved tryptophan and tyrosine residues form the binding pocket of both transporters and confer selectivity for choline and ethanolamine through cation-π interactions."
    explanation: Defines the substrate-selectivity mechanism whose disruption by patient alleles this node depends on.
  downstream:
  - target: CNS Endothelial Angiogenic Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - choline_transport_model
    description: >
      How a constrained choline supply translates into defective CNS angiogenesis is
      not established. The transport defect and the angiogenic failure are each
      demonstrated, but no intermediate has been shown to connect them in patient or
      model tissue, so the edge is curated with unknown intermediates rather than as a
      mechanism.
    evidence:
    - reference: PMID:38302740
      reference_title: MFSD7c functions as a transporter of choline at the blood-brain barrier.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Collectively, our work identifies MFSD7c as a choline exporter at the BBB and provides a foundation for future work to reveal the disease mechanisms of Fowler syndrome."
      explanation: >-
        The authors present the choline-handling defect as a foundation for future work
        on disease mechanism, which is exactly the unresolved link this edge records.
- name: Reduced Endothelial Heme Availability
  biological_scale: MOLECULAR
  description: >
    The original cellular function assigned to FLVCR2 was heme import: the protein
    binds hemin-conjugated agarose competitively, cells and oocytes expressing it take
    up more heme, siRNA knockdown reduces heme import, and overexpressing cells are
    more heme-toxicity-sensitive. That account was never shown in patient tissue and
    has been displaced as the physiological function by the 2024 choline work, but it
    has not been abandoned: endothelial heme content remains the measured variable in
    the retinal angiogenesis arm below.
  genes:
  - preferred_term: FLVCR2
    term:
      id: hgnc:20105
      label: FLVCR2
  molecular_functions:
  - preferred_term: heme transmembrane transporter activity
    term:
      id: GO:0015232
      label: heme transmembrane transporter activity
    modifier: DECREASED
  cell_types:
  - preferred_term: endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  evidence:
  - reference: PMID:20823265
    reference_title: The Fowler syndrome-associated protein FLVCR2 is an importer of heme.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Second, mammalian cells and Xenopus laevis oocytes expressing FLVCR2 display enhanced heme uptake."
    explanation: The cell-based result behind the heme-import assignment this node represents.
  - reference: PMID:38778100
    reference_title: Molecular mechanism of choline and ethanolamine transport in humans.
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: "Earlier studies concluded that FLVCR1 may function as a haem exporter8-12, whereas FLVCR2 was suggested to act as a haem importer13, yet conclusive biochemical and detailed molecular evidence remained elusive for the function of both transporters14-16."
    explanation: >-
      The structural and biochemical study that displaced heme import as FLVCR2's
      physiological function, stating that the evidence for it was never conclusive.
  downstream:
  - target: CNS Endothelial Angiogenic Dysfunction
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    hypothesis_groups:
    - heme_import_model
    description: >
      In retinal endothelium, reduced heme content de-represses NOTCH signalling and
      drives hyperproliferation, and adding a heme precursor or cell-permeable hemin
      reverses it. The named intermediate is NOTCH1 activation acting on tip/stalk
      specification.
    evidence:
    - reference: PMID:42429482
      reference_title: FLVCR2 Regulation of Intracellular Heme Modulates Vascular Tip/Stalk Specification During Retinal Angiogenesis.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Mechanistically, Flvcr2 knockdown in retinal endothelial cells led to reduced heme content and promoted NOTCH signaling and hyperproliferation that could be reversed with addition of a heme precursor."
      explanation: Supplies the heme-to-angiogenesis route, with NOTCH as the named intermediate and a rescue arm.
- name: CNS Endothelial Angiogenic Dysfunction
  biological_scale: CELLULAR
  description: >
    The primary cellular lesion is in the endothelium of the developing CNS
    vasculature, which fails to build an orderly vascular bed. Endothelial-specific
    deletion of Flvcr2 in mouse, or chemical inhibition of heme synthesis, reduces
    vascular expansion of both retinal plexuses and in a subset produces frankly
    abnormal vascular glomeruloids - the same lesion seen in human CNS. Mechanistically
    the defect sits at tip/stalk specification, with loss of FLVCR2 attenuating the
    normal restraint on NOTCH1 and on VEGF-induced proliferation.
  cell_types:
  - preferred_term: brain microvascular endothelial cell
    term:
      id: CL:2000044
      label: brain microvascular endothelial cell
  - preferred_term: retinal blood vessel endothelial cell
    term:
      id: CL:0002585
      label: retinal blood vessel endothelial cell
  biological_processes:
  - preferred_term: sprouting angiogenesis
    term:
      id: GO:0002040
      label: sprouting angiogenesis
    modifier: ABNORMAL
  - preferred_term: endothelial tip cell fate specification
    term:
      id: GO:0097102
      label: endothelial tip cell fate specification
    modifier: ABNORMAL
  - preferred_term: Notch signaling pathway
    term:
      id: GO:0007219
      label: Notch signaling pathway
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:42429482
    reference_title: FLVCR2 Regulation of Intracellular Heme Modulates Vascular Tip/Stalk Specification During Retinal Angiogenesis.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Endothelial cell-specific deletion of Flvcr2 or chemical inhibition of heme synthesis during post-natal retinal vascularization led to reduced vascular expansion in both primary (superficial) and secondary (deep) vascular plexuses, and a more severe but partially penetrant phenotype with attenuation of retinal vascular development and formation of abnormal vascular glomeruloids."
    explanation: Shows endothelial-autonomous FLVCR2 loss produces impaired vascular expansion and glomeruloid formation.
  - reference: PMID:42429482
    reference_title: FLVCR2 Regulation of Intracellular Heme Modulates Vascular Tip/Stalk Specification During Retinal Angiogenesis.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Furthermore, we found that FLVCR2/heme signaling attenuates NOTCH1 activation and affects downstream tip/stalk cell specification, while also preventing VEGF-induced proliferation."
    explanation: Identifies the tip/stalk specification step as the cellular process FLVCR2 acts on.
  downstream:
  - target: Deficient Pericyte Coverage of CNS Vessels
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Immunohistology of affected fetal CNS shows a drastic reduction in the pericyte
      marker smooth muscle actin against matched control, from which the authors infer
      a pericyte-dependent remodelling defect. Whether the pericyte deficit is caused
      by the endothelial lesion or is a parallel consequence is not established.
    evidence:
    - reference: PMID:19635601
      reference_title: "Refining the clinicopathological pattern of cerebral proliferative glomeruloid vasculopathy (Fowler syndrome): report of 16 fetal cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Interestingly in PGV, immunohistological response to a marker of pericytes (SMA, Smooth in PGV Muscle Actin), was drastically reduced as compared to a match control."
      explanation: The human histological observation of reduced pericyte marker this node records.
  - target: Glomeruloid Vascular Proliferation of CNS and Retinal Vessels
    causal_link_type: DIRECT
    description: >
      Disordered endothelial proliferation and failed sprout organisation produce the
      glomeruloid lesion itself.
    evidence:
    - reference: PMID:19635601
      reference_title: "Refining the clinicopathological pattern of cerebral proliferative glomeruloid vasculopathy (Fowler syndrome): report of 16 fetal cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Cerebral proliferative glomeruloid vasculopathy (PGV) is a severe disorder of brain angiogenesis, resulting in abnormally thickened and aberrant perforating vessels, forming glomeruloids with inclusion-bearing endothelial cells."
      explanation: Defines the lesion as the product of a disorder of brain angiogenesis.
- name: Deficient Pericyte Coverage of CNS Vessels
  biological_scale: CELLULAR
  description: >
    Pericyte marker expression is drastically reduced in affected CNS vessels. The
    authors of the sixteen-fetus series propose that the pathogenesis of the
    vasculopathy is related to abnormal pericyte-dependent remodelling of the CNS
    vasculature during angiogenesis. This is a proposal from histology, not a
    demonstrated step, and is curated as such.
  cell_types:
  - preferred_term: pericyte
    term:
      id: CL:0000669
      label: pericyte
  evidence:
  - reference: PMID:19635601
    reference_title: "Refining the clinicopathological pattern of cerebral proliferative glomeruloid vasculopathy (Fowler syndrome): report of 16 fetal cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our studies has expanded the description of FS to additional phenotypes, that could be called Fowler-like syndromes and suggest that the pathogenesis of PGV may be related to abnormal pericyte-dependent remodelling of the CNS vasculature, during CNS angiogenesis."
    explanation: States the pericyte-remodelling proposal, in the authors' own hedged terms.
  downstream:
  - target: Glomeruloid Vascular Proliferation of CNS and Retinal Vessels
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Proposed contribution of defective pericyte-dependent vascular remodelling to the
      glomeruloid lesion. Curated as a hypothesis-level edge.
    evidence:
    - reference: PMID:19635601
      reference_title: "Refining the clinicopathological pattern of cerebral proliferative glomeruloid vasculopathy (Fowler syndrome): report of 16 fetal cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "suggest that the pathogenesis of PGV may be related to abnormal pericyte-dependent remodelling of the CNS vasculature, during CNS angiogenesis"
      explanation: The proposed pericyte route to the glomeruloid lesion.
- name: Glomeruloid Vascular Proliferation of CNS and Retinal Vessels
  biological_scale: TISSUE
  description: >
    The pathognomonic lesion. Perforating vessels become abnormally thickened and
    aberrant, forming glomeruloid tufts of poorly organised endothelium with
    inclusion-bearing endothelial cells, throughout the central nervous system and the
    retinal vasculature. It was present in all fourteen fetuses of one autopsy series,
    though with variable extent of CNS involvement, and a focal form confined to
    restricted CNS territories exists alongside the classical diffuse form. Its
    confinement to the CNS is diagnostically decisive: the typical proliferative
    vasculopathy has never been observed outside the central nervous system.
  cell_types:
  - preferred_term: brain microvascular endothelial cell
    term:
      id: CL:2000044
      label: brain microvascular endothelial cell
  biological_processes:
  - preferred_term: angiogenesis
    term:
      id: GO:0001525
      label: angiogenesis
    modifier: ABNORMAL
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Histology of the brain showed the characteristic glomeruloid vascular proliferation of Fowler syndrome in all cases, but with variable extent of involvement of the central nervous system."
    explanation: Establishes the lesion as universal in the reported series with variable extent.
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The typical proliferative vasculopathy was never observed outside the central nervous system and karyotypes were normal in the 10 fetuses studied."
    explanation: Establishes the CNS confinement of the vasculopathy asserted by this node.
  - reference: PMID:20206334
    reference_title: Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "glomeruloid vasculopathy of the central nervous system and retinal vessels"
    explanation: Records the retinal vessels as the one non-brain site the lesion involves.
  downstream:
  - target: Diffuse Clastic Ischemic Injury of the Developing CNS
    causal_link_type: DIRECT
    description: >
      The disruptive impact of the vascular malformation on the developing central
      nervous system is the accepted route from lesion to brain destruction.
    evidence:
    - reference: PMID:19635601
      reference_title: "Refining the clinicopathological pattern of cerebral proliferative glomeruloid vasculopathy (Fowler syndrome): report of 16 fetal cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "In PGV, the disruptive impact of vascular malformation on the developing central nervous system (CNS) is now well admitted."
      explanation: States the causal relation between the vasculopathy and CNS damage.
  - target: Abnormal retinal vascular morphology
    causal_link_type: DIRECT
    description: The same glomeruloid lesion involves the retinal vasculature.
    evidence:
    - reference: PMID:29500860
      reference_title: "Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome or Fowler syndrome: Report of a family and insight into the disease's mechanism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "a distinctive glomerular vasculopathy in the central nervous system (CNS) and retina"
      explanation: Records retinal involvement by the characteristic vasculopathy.
- name: Diffuse Clastic Ischemic Injury of the Developing CNS
  biological_scale: TISSUE
  description: >
    Brain tissue that formed is destroyed. Diffuse clastic ischaemic lesions with
    calcification involve the brainstem, basal ganglia and spinal cord; dystrophic
    calcification and necrosis were present in every case of the fourteen-fetus autopsy
    series. This is an encephaloclastic process secondary to the vasculopathy, not a
    primary failure of neural patterning, which is what distinguishes the entity from
    the malformative causes of hydranencephaly.
  biological_processes:
  - preferred_term: brain development
    term:
      id: GO:0007420
      label: brain development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:20206334
    reference_title: Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "brain stem, basal ganglia, and spinal cord diffuse clastic ischemic lesions with calcifications"
    explanation: Names the distribution of the clastic ischaemic lesions this node represents.
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Dystrophic calcification and necrosis were always present."
    explanation: Establishes calcification and necrosis as invariable findings.
  - reference: PMID:29500860
    reference_title: "Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome or Fowler syndrome: Report of a family and insight into the disease's mechanism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Subsequent reports have shown that hydranencephaly–hydrocephaly resulted from the destruction of brain tissue due to vascular anomalies, while other features were likely secondary to CNS injuries."
    explanation: States the encephaloclastic mechanism and the secondary status of the extracranial features.
  downstream:
  - target: Hydranencephaly
    causal_link_type: DIRECT
    description: >
      Destruction of the cerebral mantle leaves a translucent membranous structure in
      place of cortex.
    evidence:
    - reference: PMID:20014121
      reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "At autopsy the cerebral cortex appeared as a translucent membranous structure (hydranencephaly) in most fetuses."
      explanation: Documents the hydranencephalic end state at autopsy.
  - target: Hydrocephalus
    causal_link_type: DIRECT
    description: Ventricular dilatation accompanies or replaces the hydranencephalic picture.
    evidence:
    - reference: PMID:20014121
      reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Antenatal ultrasonography showed hydrocephaly in all except two fetuses, but hydranencephaly was diagnosed in only one case."
      explanation: Hydrocephaly was the near-universal antenatal finding in the series.
  - target: Cerebral calcification
    causal_link_type: DIRECT
    description: Dystrophic calcification of the clastic lesions.
    evidence:
    - reference: PMID:25677735
      reference_title: Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Imaging of the brain showed calcifications, profound ventriculomegaly with only a thin edging of the cerebral cortex and hypoplastic cerebellum."
      explanation: Documents calcification on brain imaging in genetically confirmed survivors.
  - target: Spinal Cord and Brainstem Clastic Lesions with Neurogenic Muscular Atrophy
    causal_link_type: DIRECT
    description: >
      The same clastic process involves the brainstem and spinal cord, and the lower
      motor neuron loss it produces is what denervates fetal muscle.
    evidence:
    - reference: PMID:12493052
      reference_title: First-trimester features of Fowler syndrome (hydrocephaly-hydranencephaly proliferative vasculopathy).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Calcified necrotic lesions and proliferative vasculopathy were observed in the entire central nervous system including the brainstem and spinal cord."
      explanation: Documents the brainstem and spinal cord distribution of the lesions.
- name: Spinal Cord and Brainstem Clastic Lesions with Neurogenic Muscular Atrophy
  biological_scale: TISSUE
  description: >
    Involvement of the spinal cord and brainstem by the same clastic ischaemic process
    denervates fetal muscle, giving the muscular neurogenic atrophy that is part of the
    original phenotype definition. This is the node that converts a cerebrovascular
    disease into a fetal akinesia syndrome, and it is why Fowler syndrome belongs in
    the differential of lethal multiple pterygium syndrome rather than only in that of
    hydranencephaly.
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  evidence:
  - reference: PMID:20206334
    reference_title: Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a fetal akinesia deformation sequence (FADS) with muscular neurogenic atrophy"
    explanation: Names the neurogenic muscular atrophy and the akinesia sequence this node produces.
  downstream:
  - target: Fetal Akinesia Deformation Sequence
    causal_link_type: DIRECT
    description: >
      Denervation abolishes fetal movement, and immobility in utero produces the
      deformation sequence.
    evidence:
    - reference: PMID:29500860
      reference_title: "Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome or Fowler syndrome: Report of a family and insight into the disease's mechanism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Fowler syndrome is a rare autosomal recessive disorder characterized by hydranencephaly-hydrocephaly and multiple pterygium due to fetal akinesia."
      explanation: States that the pterygia arise from fetal akinesia, the link this edge asserts.
- name: Fetal Akinesia Deformation Sequence
  biological_scale: ORGANISM
  description: >
    Absent or reduced fetal movement produces a stereotyped deformation sequence:
    joint contractures, pterygia, micrognathia and postural abnormalities. In the
    fourteen-fetus series, joint contractures were present in twelve and pterygia in
    eleven, against micrognathia in ten. These are secondary mechanical consequences
    of immobility, not independent malformations, which is why they cluster so tightly
    with each other and so loosely with the severity of the cerebral lesion.
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Extra-cranial anomalies included micrognathia (10 fetuses), cleft palate (1 fetus), cystic hygroma (2 fetuses), joint contractures (12 fetuses), and pterygia (11 fetuses)."
    explanation: Quantifies the deformation-sequence features across the reported series.
  downstream:
  - target: Arthrogryposis multiplex congenita
    causal_link_type: DIRECT
    description: Joint contractures from restricted intrauterine movement.
    evidence:
    - reference: PMID:12493052
      reference_title: First-trimester features of Fowler syndrome (hydrocephaly-hydranencephaly proliferative vasculopathy).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "ultrasound examination revealed hydrocephaly-hydranencephaly, fetal akinesia, and arthrogryposis"
      explanation: Records arthrogryposis alongside the akinesia on prenatal imaging.
  - target: Pterygium
    causal_link_type: DIRECT
    description: Webbing across immobilised joints.
    evidence:
    - reference: PMID:29500860
      reference_title: "Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome or Fowler syndrome: Report of a family and insight into the disease's mechanism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "multiple pterygium due to fetal akinesia"
      explanation: Attributes the pterygia directly to fetal akinesia.
  - target: Micrognathia
    causal_link_type: DIRECT
    description: Reduced mandibular growth from absent fetal jaw movement.
    evidence:
    - reference: PMID:20014121
      reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Extra-cranial anomalies included micrognathia (10 fetuses)"
      explanation: Documents micrognathia frequency in the autopsy series.
  - target: Decreased fetal movement
    causal_link_type: DIRECT
    description: The akinesia itself, as observed antenatally.
    evidence:
    - reference: PMID:25677735
      reference_title: Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Hallmarks of the syndrome are glomerular vasculopathy in the central nervous system, severe hydrocephaly, hypokinesia and arthrogryphosis."
      explanation: Lists hypokinesia among the defining hallmarks.
phenotypes:
- category: Neurologic
  name: Hydranencephaly
  frequency: VERY_FREQUENT
  description: >
    Replacement of the cerebral mantle by a translucent membranous structure, found in
    most fetuses at autopsy even where antenatal ultrasound had reported only
    hydrocephaly.
  phenotype_term:
    preferred_term: Hydranencephaly
    term:
      id: HP:0002324
      label: Hydranencephaly
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At autopsy the cerebral cortex appeared as a translucent membranous structure (hydranencephaly) in most fetuses."
    explanation: Establishes hydranencephaly as the usual autopsy finding.
- category: Neurologic
  name: Hydrocephalus
  frequency: VERY_FREQUENT
  description: >
    Hydrocephaly was seen antenatally in all but two of fourteen fetuses, and gross
    ventriculomegaly is the imaging finding that should prompt consideration of the
    diagnosis postnatally.
  phenotype_term:
    preferred_term: Hydrocephalus
    term:
      id: HP:0000238
      label: Hydrocephalus
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Antenatal ultrasonography showed hydrocephaly in all except two fetuses"
    explanation: Frequency of antenatal hydrocephaly in the reported series.
- category: Neurologic
  name: Ventriculomegaly
  frequency: FREQUENT
  description: >
    Profound ventriculomegaly with only a thin rim of cortex is the imaging signature
    in survivors, and the systematic review argues it should trigger consideration of
    Fowler syndrome in a child rather than only in a fetus.
  phenotype_term:
    preferred_term: Ventriculomegaly
    term:
      id: HP:0002119
      label: Ventriculomegaly
  evidence:
  - reference: PMID:32333401
    reference_title: "Expanding the clinical spectrum of Fowler syndrome: Three siblings with survival into adulthood and systematic review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "it is important to consider Fowler syndrome in patients with gross ventriculomegaly, cortical malformations and/or cerebral calcifications on brain imaging."
    explanation: States the postnatal imaging presentation that should raise the diagnosis.
- category: Neurologic
  name: Cerebral calcification
  frequency: VERY_FREQUENT
  description: >
    Dystrophic calcification of the clastic lesions, invariable at autopsy and visible
    on brain imaging in survivors.
  phenotype_term:
    preferred_term: Cerebral calcification
    term:
      id: HP:0002514
      label: Cerebral calcification
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Dystrophic calcification and necrosis were always present."
    explanation: Calcification was present in every case of the series.
- category: Neurologic
  name: Cerebellar hypoplasia
  frequency: OCCASIONAL
  description: A hypoplastic cerebellum was documented on imaging in the reported survivors.
  phenotype_term:
    preferred_term: Cerebellar hypoplasia
    term:
      id: HP:0001321
      label: Cerebellar hypoplasia
  evidence:
  - reference: PMID:25677735
    reference_title: Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "profound ventriculomegaly with only a thin edging of the cerebral cortex and hypoplastic cerebellum"
    explanation: Records cerebellar hypoplasia in genetically confirmed survivors.
- category: Neurologic
  name: Seizure
  frequency: OCCASIONAL
  description: Seizures were a feature in the sibling pair who survived beyond infancy.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:25677735
    reference_title: Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "severe intellectual and neurologic disability with seizures, absence of functional movements, and no means of communication"
    explanation: Documents seizures in the survivors.
- category: Ophthalmologic
  name: Abnormal retinal vascular morphology
  frequency: FREQUENT
  description: >
    The retinal vasculature carries the same glomeruloid lesion as the CNS vessels and
    is the one site outside the brain and cord where it is found.
  phenotype_term:
    preferred_term: Abnormal retinal vascular morphology
    term:
      id: HP:0008046
      label: Abnormal retinal vascular morphology
  evidence:
  - reference: PMID:20206334
    reference_title: Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "glomeruloid vasculopathy of the central nervous system and retinal vessels"
    explanation: Records retinal vascular involvement in the phenotype definition.
- category: Musculoskeletal
  name: Arthrogryposis multiplex congenita
  frequency: VERY_FREQUENT
  description: Joint contractures were present in twelve of fourteen fetuses.
  phenotype_term:
    preferred_term: Arthrogryposis multiplex congenita
    term:
      id: HP:0002804
      label: Arthrogryposis multiplex congenita
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "joint contractures (12 fetuses), and pterygia (11 fetuses)"
    explanation: Frequency of contractures and pterygia in the autopsy series.
- category: Musculoskeletal
  name: Pterygium
  frequency: VERY_FREQUENT
  description: >
    Multiple pterygia secondary to fetal akinesia, present in eleven of fourteen
    fetuses. Their prominence is why the syndrome enters the differential of lethal
    multiple pterygium syndrome.
  phenotype_term:
    preferred_term: Pterygium
    term:
      id: HP:0001059
      label: Pterygium
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Fowler syndrome should be considered in the differential diagnosis of lethal multiple pterygium syndrome, fetal akinesia, and hydrocephalus in addition to classical hydranencephaly."
    explanation: States the differential-diagnostic significance of the pterygia.
- category: Craniofacial
  name: Micrognathia
  frequency: FREQUENT
  description: Micrognathia in ten of fourteen fetuses.
  phenotype_term:
    preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Extra-cranial anomalies included micrognathia (10 fetuses)"
    explanation: Frequency of micrognathia in the series.
- category: Craniofacial
  name: Cleft palate
  frequency: VERY_RARE
  description: Cleft palate was found in one of fourteen fetuses.
  phenotype_term:
    preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Extra-cranial anomalies included micrognathia (10 fetuses), cleft palate (1 fetus), cystic hygroma (2 fetuses), joint contractures (12 fetuses), and pterygia (11 fetuses)."
    explanation: >-
      Records the single cleft palate in the series; the quoted sentence is the
      full extra-cranial tally the count sits inside.
- category: Prenatal
  name: Decreased fetal movement
  frequency: VERY_FREQUENT
  description: >
    Hypokinesia is one of the defining hallmarks and is detectable antenatally.
  phenotype_term:
    preferred_term: Decreased fetal movement
    term:
      id: HP:0001558
      label: Decreased fetal movement
  evidence:
  - reference: PMID:25677735
    reference_title: Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Hallmarks of the syndrome are glomerular vasculopathy in the central nervous system, severe hydrocephaly, hypokinesia and arthrogryphosis."
    explanation: Lists hypokinesia as a hallmark.
- category: Prenatal
  name: Cystic hygroma
  frequency: OCCASIONAL
  description: >
    Cystic hygroma in two of fourteen fetuses, and in one pregnancy it was the finding
    at 12 weeks that prompted referral.
  phenotype_term:
    preferred_term: Cystic hygroma
    term:
      id: HP:0000476
      label: Cystic hygroma
  evidence:
  - reference: PMID:12493052
    reference_title: First-trimester features of Fowler syndrome (hydrocephaly-hydranencephaly proliferative vasculopathy).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The pregnancy with no significant family history was referred for karyotyping and ultrasound examination after a cystic hygroma was seen at 12 weeks."
    explanation: Documents cystic hygroma as a first-trimester presenting sign.
- category: Craniofacial
  name: Microcephaly
  frequency: FREQUENT
  description: >
    Microcephaly is listed among the cardinal features of the condition in the recent
    functional literature.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:40133703
    reference_title: A hypomorphic FLVCR2 variant resulting in moderate transport deficiency causes hydranencephaly syndrome with brain calcifications.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This often-lethal condition features microcephaly, skeletal deformities, and severe cerebrovascular defects."
    explanation: Names microcephaly among the condition's features.
animal_models:
- name: Mfsd7c-null mouse
  species: Mouse
  genotype: Mfsd7c knockout (Mfsd7c-/-)
  publication: PMID:38302740
  description: >
    Constitutive knockout of the murine FLVCR2 ortholog. Metabolomics of knockout
    embryos shows choline-related metabolites altered in brain but not liver, which is
    what localises the defect to the blood-brain barrier rather than to systemic
    choline handling. The model is also the source of the directionality problem
    curated below: endothelial-specific deletion suppressed import of exogenous choline
    from blood yet raised brain choline, and stable-isotope tracing implicated the
    carrier in exporting lysophosphatidylcholine-derived choline instead.
  genes:
  - preferred_term: FLVCR2
    term:
      id: hgnc:20105
      label: FLVCR2
  modeled_mechanisms:
  - target: Failure of Brain Choline Supply
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    model_scale: MOLECULAR
    description: >
      The knockout reproduces a brain-restricted disturbance of choline handling, which
      is the substrate-level claim of the node. It does not settle the direction of
      transport, and the brain choline concentration moved opposite to the direction a
      simple import failure predicts.
    limitations: >
      Mouse, and constitutive rather than allele-matched to any patient genotype. The
      central discrepancy is unresolved within the model itself: brain choline rose
      rather than fell on endothelial deletion, so the model supports a choline-handling
      defect without supporting brain choline deficiency as such.
    readouts:
    - name: Brain choline-related metabolite profile
      target: Failure of Brain Choline Supply
      direction: ALTERED
      interpretation: >
        Choline-related metabolites are altered in knockout brain but not liver,
        localising the transport defect to the blood-brain barrier.
      evidence:
      - reference: PMID:38302740
        reference_title: MFSD7c functions as a transporter of choline at the blood-brain barrier.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Particularly, we found that choline-related metabolites were altered in the brains but not in the livers of Mfsd7c-/- embryos."
        explanation: The measurement grounding this readout and its tissue specificity.
    - name: Brain choline concentration after endothelial-specific deletion
      target: Failure of Brain Choline Supply
      direction: INCREASED
      interpretation: >
        A negative result for the simple import model: suppressing blood-derived choline
        import raised rather than lowered brain choline.
      evidence:
      - reference: PMID:38302740
        reference_title: MFSD7c functions as a transporter of choline at the blood-brain barrier.
        supports: REFUTE
        evidence_source: MODEL_ORGANISM
        snippet: "Mice lacking Mfsd7c in endothelial cells of the central nervous system suppressed the import of exogenous choline from blood but unexpectedly had increased choline levels in the brain."
        explanation: >-
          Quantified in the direction opposite to that predicted by a pure import
          failure, which is why it is graded REFUTE against this node's claim.
    evidence:
    - reference: PMID:38302740
      reference_title: MFSD7c functions as a transporter of choline at the blood-brain barrier.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Here, we used Mfsd7c knockout (Mfsd7c-/-) mice and cell-based assays to reveal that MFSD7c is a choline transporter at the blood-brain barrier (BBB)."
      explanation: Establishes the model and what it is informative for.
- name: Endothelial-specific Flvcr2 conditional knockout mouse
  species: Mouse
  genotype: Endothelial cell-specific Flvcr2 conditional knockout
  publication: PMID:42429482
  description: >
    Conditional deletion restricted to endothelium, assayed during post-natal retinal
    vascularization. It is the cleanest available demonstration that the angiogenic
    defect is endothelium-autonomous, and it reproduces the glomeruloid lesion itself
    in a tissue that can be imaged whole-mount.
  genes:
  - preferred_term: FLVCR2
    term:
      id: hgnc:20105
      label: FLVCR2
  modeled_mechanisms:
  - target: CNS Endothelial Angiogenic Dysfunction
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: CELLULAR
    description: >
      Endothelium-restricted loss of Flvcr2 produces reduced vascular expansion and, in
      a subset, abnormal vascular glomeruloids - the human lesion - establishing that
      the angiogenic defect does not require loss of the transporter in any other cell
      type.
    limitations: >
      The vascular bed is retina rather than brain, and the timing is post-natal rather
      than the mid-gestation window in which the human disease destroys the brain. The
      severe phenotype is partially penetrant.
    readouts:
    - name: Retinal vascular plexus expansion
      target: CNS Endothelial Angiogenic Dysfunction
      direction: DECREASED
      interpretation: Reduced angiogenic outgrowth in both superficial and deep plexuses.
      evidence:
      - reference: PMID:42429482
        reference_title: FLVCR2 Regulation of Intracellular Heme Modulates Vascular Tip/Stalk Specification During Retinal Angiogenesis.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "led to reduced vascular expansion in both primary (superficial) and secondary (deep) vascular plexuses"
        explanation: The quantified angiogenic deficit behind this readout.
    evidence:
    - reference: PMID:42429482
      reference_title: FLVCR2 Regulation of Intracellular Heme Modulates Vascular Tip/Stalk Specification During Retinal Angiogenesis.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Here, we use conditional knockout of Flvcr2 in mice and knockdown in primary bovine retinal endothelial cell culture to explore retinal development and associated mechanisms of angiogenic regulation by FLVCR2."
      explanation: Establishes the model system and its purpose.
mechanistic_hypotheses:
- hypothesis_group_id: choline_transport_model
  hypothesis_label: FLVCR2 Choline/Ethanolamine Transport Model
  status: CANONICAL
  description: >-
    FLVCR2 is a choline and ethanolamine carrier at the blood-brain barrier, selecting
    its substrates through cation-pi interactions in a conserved aromatic pocket.
    Disease alleles disrupt that transport, constraining the brain's supply of a
    nutrient it cannot make for itself, and the developing CNS vasculature fails. This
    is the current physiological account, established in 2024 by independent structural
    and functional work, and it is the model against which a clinical allele has been
    assayed directly.
  evidence:
  - reference: PMID:38693257
    reference_title: Structural and molecular basis of choline uptake into the brain by FLVCR2.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Here we demonstrate both in vivo and in vitro that FLVCR2 is a BBB choline transporter and is responsible for the majority of choline uptake into the brain."
    explanation: The primary demonstration that FLVCR2 is the blood-brain-barrier choline transporter.
  - reference: PMID:38778100
    reference_title: Molecular mechanism of choline and ethanolamine transport in humans.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Here, we show that FLVCR1 and FLVCR2 facilitate the transport of choline and ethanolamine across the plasma membrane, using a concentration-driven substrate translocation process."
    explanation: Independent structural and biochemical identification of the substrates.
  - reference: PMID:40133703
    reference_title: A hypomorphic FLVCR2 variant resulting in moderate transport deficiency causes hydranencephaly syndrome with brain calcifications.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our findings suggest that FLVCR2 deficiency may be sufficient to cause PVHH even in the absence of a complete loss of transport activity, possibly involving extragenetic factors in the pathophysiology of this complex condition."
    explanation: >-
      Applies the model to a patient allele and finds partial transport loss sufficient,
      while flagging that extragenetic factors are likely involved.
- hypothesis_group_id: heme_import_model
  hypothesis_label: FLVCR2 Heme-Import Model
  status: ALTERNATIVE
  description: >-
    The original account, in which FLVCR2 imports heme and disease alleles produce an
    endothelial heme deficit. It was the field's working model from 2010 and was
    supported by structural interpretation of the patient mutation set, but it was never
    demonstrated in patient tissue and the 2024 substrate work states that conclusive
    evidence for it never existed. It is retained as ALTERNATIVE rather than DEPRECATED
    because endothelial heme content remains a measured, manipulable variable with a
    mechanistic route to the angiogenic phenotype: reducing it de-represses NOTCH and
    perturbs tip/stalk specification, and heme precursor or hemin reverses that.
  evidence:
  - reference: PMID:20823265
    reference_title: The Fowler syndrome-associated protein FLVCR2 is an importer of heme.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Here, we report the cellular function of FLVCR2 as an importer of heme, based on the following observations."
    explanation: The study that established the heme-import model.
  - reference: PMID:42429482
    reference_title: FLVCR2 Regulation of Intracellular Heme Modulates Vascular Tip/Stalk Specification During Retinal Angiogenesis.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Collectively, these data indicate a newly identified role for FLVCR2 and heme in the regulation of tip/stalk specification in angiogenesis."
    explanation: Recent in vivo work sustaining a heme-dependent route to the angiogenic phenotype.
  - reference: PMID:38778100
    reference_title: Molecular mechanism of choline and ethanolamine transport in humans.
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: "Earlier studies concluded that FLVCR1 may function as a haem exporter8-12, whereas FLVCR2 was suggested to act as a haem importer13, yet conclusive biochemical and detailed molecular evidence remained elusive for the function of both transporters14-16."
    explanation: States that the biochemical basis for the heme-import assignment was never conclusive.
diagnosis:
- name: Prenatal ultrasound
  description: >
    Fowler syndrome is usually first suspected on fetal imaging. Hydrocephaly or
    hydranencephaly together with a fetal akinesia deformation sequence, detectable
    from the end of the first trimester, is the trigger to consider the diagnosis.
    Imaging raises the suspicion; it does not establish the diagnosis, which rests on
    neuropathology or molecular testing.
  diagnosis_term:
    preferred_term: prenatal ultrasound imaging
    term:
      id: NCIT:C17230
      label: Ultrasound Imaging
  evidence:
  - reference: PMID:12493052
    reference_title: First-trimester features of Fowler syndrome (hydrocephaly-hydranencephaly proliferative vasculopathy).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis of proliferative vasculopathy and hydrocephaly-hydranencephaly (Fowler syndrome) should be considered whenever hydrocephaly-hydranencephaly associated with a fetal akinetic sequence are encountered at the end of the first trimester. Genetic counseling is recommended."
    explanation: >-
      States the sonographic trigger and the gestational age at which it becomes
      apparent, which is what makes ultrasound the entry point to the diagnostic
      pathway.
- name: Neuropathological examination at autopsy
  description: >
    Autopsy with examination of the brain is what distinguishes Fowler syndrome from
    the other causes of hydrocephaly and hydranencephaly, by demonstrating the
    glomeruloid vasculopathy and diffuse clastic ischemic lesions. Because those other
    causes may carry a lower recurrence risk than this disorder's one-in-four, the
    distinction changes the counselling given for the next pregnancy.
  diagnosis_term:
    preferred_term: autopsy
    term:
      id: NCIT:C25153
      label: Autopsy
  evidence:
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Autopsy and study of the brain are essential to differentiate autosomal recessive Fowler syndrome from other causes of hydrocephaly and hydranencephaly, which may have a lower recurrence risk."
    explanation: >-
      States that autopsy is essential to differentiate this disorder, and gives the
      recurrence-risk reason the differentiation matters.
- name: FLVCR2 molecular genetic testing
  description: >
    Identification of biallelic FLVCR2 variants confirms the diagnosis molecularly and
    is what allows recurrence-risk counselling and prenatal or preimplantation testing
    in a subsequent pregnancy without relying on autopsy of an affected fetus.
  diagnosis_term:
    preferred_term: FLVCR2 sequencing
    term:
      id: NCIT:C19770
      label: Molecular Analysis
  evidence:
  - reference: PMID:20206334
    reference_title: Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Direct sequencing of candidate genes within the target interval revealed five different germline mutations in FLVCR2 in five families with Fowler syndrome."
    explanation: >-
      Establishes FLVCR2 sequencing as the route to a molecular diagnosis. INDIRECT
      because the paper reports gene discovery in five families rather than evaluating
      sequencing as a diagnostic test, so its sensitivity in unselected cases is not
      addressed here.
treatments:
- name: Genetic counseling and recurrence-risk assessment
  description: >
    There is no disease-modifying therapy. Management is prenatal diagnosis, counselling
    about the autosomal recessive recurrence risk, and discussion of options; several
    reported pregnancies ended in termination. Distinguishing Fowler syndrome at autopsy
    from other causes of hydrocephaly and hydranencephaly matters precisely because it
    carries a one-in-four recurrence risk where those other causes may not.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  therapeutic_modality: BEHAVIORAL
  evidence:
  - reference: PMID:12493052
    reference_title: First-trimester features of Fowler syndrome (hydrocephaly-hydranencephaly proliferative vasculopathy).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis of proliferative vasculopathy and hydrocephaly-hydranencephaly (Fowler syndrome) should be considered whenever hydrocephaly-hydranencephaly associated with a fetal akinetic sequence are encountered at the end of the first trimester. Genetic counseling is recommended."
    explanation: >-
      The closing sentence recommends genetic counselling, which is the management
      this entry records. The diagnostic trigger in the same quote is carried by the
      prenatal-ultrasound item under diagnosis.
inheritance:
- name: Autosomal recessive
  description: >
    Biallelic FLVCR2 variants. Affected sibships and consanguinity are both common: in
    one series of fourteen fetuses from ten families, sibs were affected in four
    families and the parents were consanguineous in six.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:20206334
    reference_title: Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "is an autosomal-recessively inherited prenatal lethal disorder"
    explanation: States the mode of inheritance.
  - reference: PMID:20014121
    reference_title: Fowler syndrome-a clinical, radiological, and pathological study of 14 cases.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In four families sibs were affected and in six the parents were consanguineous."
    explanation: Documents the sibship recurrence and consanguinity consistent with recessive inheritance.
genetic:
- name: FLVCR2 variants
  gene_term:
    preferred_term: FLVCR2
    term:
      id: hgnc:20105
      label: FLVCR2
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  inheritance:
  - name: Autosomal recessive
    evidence:
    - reference: PMID:25677735
      reference_title: Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "is a rare autosomal recessive disorder, caused by mutations in FLVCR2"
      explanation: Establishes biallelic FLVCR2 causation.
  variants:
  - name: Homozygous FLVCR2 c.1289C>T
    description: >
      The allele in the first reported patients to survive beyond infancy, a brother and
      sister homozygous for it, identified by whole-exome sequencing.
    evidence:
    - reference: PMID:25677735
      reference_title: Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Investigation with whole-exome sequencing (WES) revealed, in both patients, a homozygous pathogenic mutation in FLVCR2, c.1289C>T, compatible with a diagnosis of Fowler syndrome."
      explanation: Names the allele and the method by which it was found.
  - name: Compound heterozygous c.327T>A (p.Asn109Lys) and c.887C>T (p.Ser296Leu)
    description: >
      Shared by three siblings who survived into adulthood, two with the cerebral
      features seen in affected fetuses and one considerably milder - the clearest
      published demonstration that genotype does not fix phenotype in this disease.
    evidence:
    - reference: PMID:32333401
      reference_title: "Expanding the clinical spectrum of Fowler syndrome: Three siblings with survival into adulthood and systematic review of the literature."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Although our three patients carry the same mutations (c.327T>A-p.Asn109Lys and c.887C>T-p.Ser296Leu) in FLVCR2, only two of them presented with the same cerebral features, ventriculomegaly and cerebral calcifications, as affected fetuses."
      explanation: Names the alleles and documents the intrafamilial discordance.
  - name: Compound heterozygous c.1124+3_1124+6del and p.(Arg492Trp)
    description: >
      A fetal case in which both alleles were functionally characterised: the splice
      variant impairs exon 5 splicing on minigene assay, and p.(Arg492Trp) was modelled
      as highly destabilising and shown to cut transport activity by half, leaving net
      activity of a quarter to a third.
    evidence:
    - reference: PMID:40133703
      reference_title: A hypomorphic FLVCR2 variant resulting in moderate transport deficiency causes hydranencephaly syndrome with brain calcifications.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Through exome sequencing, we identified two compound heterozygous FLVCR2 variants: the maternal c.1124+3_1124+6del and the paternal p.(Arg492Trp)."
      explanation: Names the two alleles in the functionally characterised fetal case.
  features: >
    Genetic homogeneity is the rule: no second locus has been reported since the gene
    was identified in 2010. No clear genotype-phenotype correlation exists, though some
    variants do appear to be associated with a phenotype mild enough to be compatible
    with life.
  evidence:
  - reference: PMID:29500860
    reference_title: "Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome or Fowler syndrome: Report of a family and insight into the disease's mechanism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The present report confirms the genetic homogeneity of Fowler syndrome and describes a new FLVCR2 mutation affecting the protein function."
    explanation: States the genetic homogeneity of the disorder.
  - reference: PMID:32333401
    reference_title: "Expanding the clinical spectrum of Fowler syndrome: Three siblings with survival into adulthood and systematic review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Although no clear phenotype-genotype correlation exists, some variants appear to be associated with a less severe phenotype compatible with life."
    explanation: States the absence of a clear genotype-phenotype correlation.
discussions:
- discussion_id: flvcr2_transport_direction_and_substrate
  prompt: >-
    Does FLVCR2 import choline into the brain across the blood-brain barrier, export
    lysophosphatidylcholine-derived choline out of it, or act principally as a heme
    importer - and which of these, if any, is the step whose failure causes the
    vasculopathy?
  kind: CONTROVERSY
  status: OPEN
  attaches_to:
  - pathophysiology#Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane
  - mechanistic_hypotheses#choline_transport_model
  - mechanistic_hypotheses#heme_import_model
  rationale: >-
    Three readings of the same protein are live in the literature at once, and they are
    not simply a chronological succession. The 2010 heme-import assignment rested on
    binding, uptake, knockdown and toxicity experiments in cells, and structural
    analysis of patient alleles was later read as supporting it; the 2024 structural
    work states that conclusive evidence for it never existed and identifies choline and
    ethanolamine as the physiological substrates. But the two 2024 choline papers
    disagree with each other on direction: one demonstrates FLVCR2 as the blood-brain
    barrier choline importer responsible for most brain choline uptake, while the other,
    from endothelial-specific knockouts, finds brain choline paradoxically increased and
    concludes the carrier exports lysophosphatidylcholine-derived choline instead. And a
    2026 retinal study revives heme as the operative variable, with a rescue arm. This
    entry therefore does not pick a winner: both substrate arms are curated as
    hypothesis groups converging on one endothelial node, and the causal edges from
    either substrate to the angiogenic defect are marked with unknown or named
    intermediates rather than asserted as mechanism.
  proposed_experiments:
  - experiment_id: exp_flvcr2_directional_flux_in_patient_derived_bbb
    name: Directional choline flux across patient-genotype brain endothelium
    description: >-
      Build a blood-brain-barrier model from iPSC-derived brain microvascular
      endothelial cells carrying defined patient FLVCR2 genotypes, including the
      hypomorphic p.(Arg492Trp), and measure luminal-to-abluminal and
      abluminal-to-luminal choline flux separately with stable-isotope tracing. The
      published import and export claims were made in different systems, so measuring
      both directions in one human system with matched genotypes is the discriminating
      experiment.
    perturbations:
    - name: Introduce patient FLVCR2 genotypes into iPSC-derived brain endothelium
      target: pathophysiology#Impaired FLVCR2 Solute Transport at the CNS Endothelial Membrane
    readouts:
    - name: Direction-resolved choline flux
      target: pathophysiology#Failure of Brain Choline Supply
    would_support:
    - pathophysiology#Failure of Brain Choline Supply
  - experiment_id: exp_flvcr2_heme_vs_choline_rescue
    name: Substrate rescue arms in an angiogenic assay of FLVCR2-deficient endothelium
    description: >-
      In the same FLVCR2-deficient endothelial angiogenesis assay, compare rescue by
      heme precursor or cell-permeable hemin against rescue by choline or
      phosphatidylcholine supplementation. The heme rescue has been shown; the choline
      rescue has not been tested head to head against it, and whichever restores sprout
      organisation identifies the limiting substrate for the phenotype rather than for
      the transporter.
    perturbations:
    - name: Heme precursor versus choline supplementation of FLVCR2-deficient endothelium
      target: pathophysiology#Reduced Endothelial Heme Availability
    readouts:
    - name: Restoration of organised sprouting and loss of glomeruloid formation
      target: pathophysiology#CNS Endothelial Angiogenic Dysfunction
    would_support:
    - pathophysiology#Reduced Endothelial Heme Availability
  evidence:
  - reference: PMID:38302740
    reference_title: MFSD7c functions as a transporter of choline at the blood-brain barrier.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Collectively, our work identifies MFSD7c as a choline exporter at the BBB and provides a foundation for future work to reveal the disease mechanisms of Fowler syndrome."
    explanation: The export conclusion that sits against the import conclusion of the companion 2024 work.
  - reference: PMID:38693257
    reference_title: Structural and molecular basis of choline uptake into the brain by FLVCR2.
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    snippet: "Here we demonstrate both in vivo and in vitro that FLVCR2 is a BBB choline transporter and is responsible for the majority of choline uptake into the brain."
    explanation: >-
      Graded REFUTE against the export reading: the same year, in the same protein, this
      study concludes FLVCR2 is the importer responsible for most brain choline uptake.
- discussion_id: fowler_syndrome_survival_determinants
  prompt: >-
    Why do a small minority of patients with biallelic FLVCR2 variants survive beyond
    birth, and what determines phenotype when genotype does not?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - progression#Survival beyond infancy with profound disability
  - genetic#FLVCR2 variants
  rationale: >-
    Six of seventy-two published patients survived beyond birth, and no clear
    genotype-phenotype correlation explains which. The decisive observation is
    intrafamilial: three siblings carrying identical compound heterozygous alleles
    diverged, two showing the fetal cerebral phenotype and one markedly milder. Since
    the alleles are the same, whatever separates them is not the FLVCR2 genotype. The
    functional work points the same way - a patient allele retaining a quarter to a
    third of transport activity still produced the disease, and the authors explicitly
    raise extragenetic factors. Candidates include modifier loci acting on choline or
    heme handling, stochastic variation in the timing of the angiogenic insult relative
    to the vulnerable window of brain development, and maternal nutritional choline
    supply - none tested.
  proposed_experiments:
  - experiment_id: exp_fowler_survivor_modifier_search
    name: Genome-wide modifier search across the surviving cohort
    description: >-
      Sequence and compare survivors against lethal cases matched on FLVCR2 genotype
      where possible, beginning with the discordant sibships that already exist in the
      literature, and test candidate modifiers in the choline and heme handling pathways.
      The discordant-sibling families are the highest-information available material
      because they hold the primary genotype constant.
    readouts:
    - name: Modifier variants segregating with survival
      target: genetic#FLVCR2 variants
  evidence:
  - reference: PMID:32333401
    reference_title: "Expanding the clinical spectrum of Fowler syndrome: Three siblings with survival into adulthood and systematic review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The third sibling has a surprisingly milder clinical and radiological phenotype, suggesting intrafamilial variability."
    explanation: The intrafamilial discordance at constant genotype that this gap records.
  - reference: PMID:40133703
    reference_title: A hypomorphic FLVCR2 variant resulting in moderate transport deficiency causes hydranencephaly syndrome with brain calcifications.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "possibly involving extragenetic factors in the pathophysiology of this complex condition"
    explanation: The authors' own statement that extragenetic factors are likely at work.
notes: >-
  Curated for IEMbase metabolic work-package WP-006 row 2.3.06.01 (issue #5561).
  NEC preflight on MONDO:0009168 "Fowler syndrome": xref OMIM:225790 matches the seed
  row, and Orphanet:221126 is the corresponding Orphanet concept. The disease-causing
  gene is FLVCR2 (hgnc:20105, gene OMIM 610865), read from the HGNC REST API in the same
  step the binding was written; note FLVCR1 (hgnc:24682) is a different gene causing
  different diseases and is already curated separately here as FLVCR1-Related
  Retinopathy, so the FLVCR1/FLVCR2 pair is a named-entity-confusion hazard for anything
  resolving "FLVCR" by prefix.

  Two audit notes for the next curator of this package. First, the WP-006 row list is
  stale on the polyamine arm: rows 2.4.11.01 (SMS) and 2.4.13.01 (ODC1) are already
  curated as Snyder-Robinson_Syndrome and Bachmann-Bupp_Syndrome, and SLC44A1 (2.3.04.01)
  and FLVCR1 (2.3.05.01) are likewise covered. Second, no conforms_to is declared. The
  KB has no CNS-angiogenesis or blood-brain-barrier-development module, and the nearest
  candidate, norrin_fzd4_retinal_vascular_development, scopes itself to
  Norrin-FZD4-beta-catenin signalling in retinal endothelium - a different pathway in a
  different bed. A CNS angiogenesis module would be the right home for the
  tip/stalk-specification and glomeruloid nodes if a second conformer appears.